ONTOLOGY REPORT - ANNOTATIONS
| Term: | pyrimidines |
|
| Accession: | CHEBI:39447
|
browse the term
|
| Definition: | Any compound having a pyrimidine as part of its structure. |
| Synonyms: | alt_id: | CHEBI:13681; CHEBI:26448 |
|
|
(E,E)-hydramethylnon
|
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
affects binding |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
2'-deoxycytidine
|
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Dck |
deoxycytidine kinase |
|
affects binding |
ISO |
14 |
20,886,700 |
20,904,305 |
RGD:6480464 |
CTD |
| G |
Slc28a1 |
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
|
increases transport |
ISO |
1 |
137,323,995 |
137,365,983 |
RGD:6480464 |
CTD |
3'-CMP
|
| G |
Cdipt |
CDP-diacylglycerol--inositol 3-phosphatidyltransferase |
|
multiple interactions |
ISO |
1 |
186,153,278 |
186,157,415 |
RGD:6480464 |
CTD |
3-(5-fluorouracil-1-yl)-L-alanine
|
| G |
Gria3 |
glutamate receptor, ionotropic, AMPA 3 |
|
affects response to substance |
ISO |
X |
3,452,523 |
3,718,486 |
RGD:6480464 |
CTD |
5-fluorocytidine
|
| G |
Cda |
cytidine deaminase |
|
increases metabolic processing |
ISO |
5 |
157,117,303 |
157,143,989 |
RGD:6480464 |
CTD |
| G |
Cda |
cytidine deaminase |
|
increases metabolic processing |
ISO |
5 |
157,117,303 |
157,143,989 |
RGD:6480464 |
CTD |
5-fluorouracil
|
| G |
Dennd2c |
DENN/MADD domain containing 2C |
|
affects expression |
ISO |
2 |
198,362,076 |
198,401,282 |
RGD:6480464 |
CTD |
| G |
Foxc1 |
forkhead box C1 |
|
affects expression |
ISO |
17 |
39,026,186 |
39,030,163 |
RGD:6480464 |
CTD |
| G |
Gdf1 |
growth differentiation factor 1 |
|
multiple interactions |
ISO |
16 |
19,580,807 |
19,596,415 |
RGD:6480464 |
CTD |
| G |
Gem |
GTP binding protein overexpressed in skeletal muscle |
|
affects expression |
ISO |
5 |
25,809,543 |
26,008,249 |
RGD:6480464 |
CTD |
| G |
Hist1h2bk |
histone cluster 1, H2bk |
|
decreases expression |
ISO |
17 |
50,118,776 |
50,119,156 |
RGD:6480464 |
CTD |
| G |
Hist1h2bk |
histone cluster 1, H2bk |
|
affects response to substance |
ISO |
17 |
50,118,776 |
50,119,156 |
RGD:6480464 |
CTD |
| G |
LOC100360940 |
diablo-like |
|
increases response to substance |
ISO |
5 |
148,562,065 |
148,563,619 |
RGD:6480464 |
CTD |
| G |
LOC100360940 |
diablo-like |
|
increases expression |
ISO |
5 |
148,562,065 |
148,563,619 |
RGD:6480464 |
CTD |
capecitabine
|
| G |
Abcb7 |
ATP-binding cassette, subfamily B (MDR/TAP), member 7 |
|
decreases response to substance |
ISO |
X |
92,280,115 |
92,430,426 |
RGD:6480464 |
CTD |
| G |
Acaa1a |
acetyl-Coenzyme A acyltransferase 1A |
|
increases response to substance |
ISO |
8 |
124,305,097 |
124,313,887 |
RGD:6480464 |
CTD |
| G |
Agpat2 |
1-acylglycerol-3-phosphate O-acyltransferase 2 |
|
increases response to substance |
ISO |
3 |
4,769,863 |
4,781,045 |
RGD:6480464 |
CTD |
| G |
Agr2 |
anterior gradient 2 homolog (Xenopus laevis) |
|
increases response to substance |
ISO |
6 |
54,695,633 |
54,716,858 |
RGD:6480464 |
CTD |
| G |
Akr1b1 |
aldo-keto reductase family 1, member B1 (aldose reductase) |
|
decreases response to substance |
ISO |
4 |
61,645,438 |
61,659,530 |
RGD:6480464 |
CTD |
| G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
|
increases response to substance |
ISO |
17 |
77,269,626 |
77,286,521 |
RGD:6480464 |
CTD |
| G |
Arl4d |
ADP-ribosylation factor-like 4D |
|
decreases response to substance |
ISO |
10 |
90,700,469 |
90,702,625 |
RGD:6480464 |
CTD |
| G |
Axl |
Axl receptor tyrosine kinase |
|
decreases response to substance |
ISO |
1 |
80,964,751 |
80,994,300 |
RGD:6480464 |
CTD |
| G |
Canx |
calnexin |
|
multiple interactions |
ISO |
10 |
35,850,944 |
35,883,494 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
decreases expression |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Ces2h |
carboxylesterase 2H |
|
increases response to substance |
ISO |
19 |
34,910,981 |
34,925,547 |
RGD:6480464 |
CTD |
| G |
Ces2h |
carboxylesterase 2H |
|
multiple interactions |
ISO |
19 |
34,910,981 |
34,925,547 |
RGD:6480464 |
CTD |
| G |
Cib1 |
calcium and integrin binding 1 (calmyrin) |
|
increases response to substance |
ISO |
1 |
136,031,865 |
136,045,153 |
RGD:6480464 |
CTD |
| G |
Cldn3 |
claudin 3 |
|
increases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyr61 |
cysteine-rich, angiogenic inducer, 61 |
|
decreases response to substance |
ISO |
2 |
243,824,303 |
243,827,262 |
RGD:6480464 |
CTD |
| G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
increases expression |
ISO |
2 |
214,931,901 |
215,818,809 |
RGD:6480464 |
CTD |
| G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
affects response to substance |
ISO |
2 |
214,931,901 |
215,818,809 |
RGD:6480464 |
CTD |
| G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
decreases response to substance |
ISO |
2 |
214,931,901 |
215,818,809 |
RGD:6480464 |
CTD |
| G |
Dse |
dermatan sulfate epimerase |
|
decreases response to substance |
ISO |
20 |
37,568,889 |
37,647,574 |
RGD:6480464 |
CTD |
| G |
Eps8 |
epidermal growth factor receptor pathway substrate 8 |
|
increases response to substance |
ISO |
4 |
174,601,291 |
174,672,247 |
RGD:6480464 |
CTD |
| G |
Erbb3 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) |
|
increases response to substance |
ISO |
7 |
1,858,057 |
1,877,353 |
RGD:6480464 |
CTD |
| G |
Fhl1 |
four and a half LIM domains 1 |
|
decreases response to substance |
ISO |
X |
141,315,765 |
141,329,278 |
RGD:6480464 |
CTD |
| G |
Flii |
flightless I homolog (Drosophila) |
|
decreases response to substance |
ISO |
10 |
46,860,271 |
46,874,196 |
RGD:6480464 |
CTD |
| G |
Fuca1 |
fucosidase, alpha-L- 1, tissue |
|
increases response to substance |
ISO |
5 |
154,703,722 |
154,720,971 |
RGD:6480464 |
CTD |
| G |
Hdgfrp3 |
hepatoma-derived growth factor, related protein 3 |
|
decreases response to substance |
ISO |
1 |
138,098,818 |
138,130,696 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
decreases response to substance |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
decreases response to substance |
ISO |
1 |
201,385,705 |
201,388,987 |
RGD:6480464 |
CTD |
| G |
Il17rb |
interleukin 17 receptor B |
|
increases response to substance |
ISO |
16 |
5,335,806 |
5,349,160 |
RGD:6480464 |
CTD |
| G |
Il1r2 |
interleukin 1 receptor, type II |
|
increases response to substance |
ISO |
9 |
39,279,397 |
39,319,672 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
multiple interactions |
ISO |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Lgals4 |
lectin, galactoside-binding, soluble, 4 |
|
increases response to substance |
ISO |
1 |
83,942,899 |
83,950,613 |
RGD:6480464 |
CTD |
| G |
Mdm4 |
Mdm4 p53 binding protein homolog (mouse) |
|
multiple interactions |
ISO |
13 |
45,895,832 |
45,931,421 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mre11a |
MRE11 meiotic recombination 11 homolog A (S. cerevisiae) |
|
decreases response to substance |
ISO |
8 |
11,588,409 |
11,632,483 |
RGD:6480464 |
CTD |
| G |
Myrf |
myelin regulatory factor |
|
increases response to substance |
ISO |
1 |
212,699,254 |
212,726,526 |
RGD:6480464 |
CTD |
| G |
Pkd2 |
polycystic kidney disease 2 (autosomal dominant) |
|
decreases response to substance |
ISO |
14 |
6,349,519 |
6,392,988 |
RGD:6480464 |
CTD |
| G |
Pkp2 |
plakophilin 2 |
|
increases response to substance |
ISO |
11 |
86,553,493 |
86,584,425 |
RGD:6480464 |
CTD |
| G |
Plce1 |
phospholipase C, epsilon 1 |
|
increases response to substance |
ISO |
1 |
242,794,858 |
243,103,437 |
RGD:6480464 |
CTD |
| G |
Ppa1 |
pyrophosphatase (inorganic) 1 |
|
increases response to substance |
ISO |
20 |
29,015,647 |
29,042,399 |
RGD:6480464 |
CTD |
| G |
Prkacb |
protein kinase, cAMP dependent, catalytic, beta |
|
decreases response to substance |
ISO |
2 |
244,949,303 |
245,035,266 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptpn13 |
protein tyrosine phosphatase, non-receptor type 13 |
|
decreases response to substance |
ISO |
14 |
7,298,209 |
7,433,464 |
RGD:6480464 |
CTD |
| G |
Pygb |
phosphorylase, glycogen; brain |
|
increases response to substance |
ISO |
3 |
141,421,421 |
141,468,094 |
RGD:6480464 |
CTD |
| G |
Rab40b |
Rab40b, member RAS oncogene family |
|
increases response to substance |
ISO |
10 |
110,590,703 |
110,618,223 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
multiple interactions |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rbbp4 |
retinoblastoma binding protein 4 |
|
multiple interactions |
ISO |
5 |
148,472,397 |
148,492,172 |
RGD:6480464 |
CTD |
| G |
Rpa1 |
replication protein A1 |
|
decreases response to substance |
ISO |
10 |
62,613,169 |
62,656,565 |
RGD:6480464 |
CTD |
| G |
Rras2 |
related RAS viral (r-ras) oncogene homolog 2 |
|
decreases response to substance |
ISO |
1 |
172,026,262 |
172,097,710 |
RGD:6480464 |
CTD |
| G |
Stip1 |
stress-induced phosphoprotein 1 |
|
decreases response to substance |
ISO |
1 |
209,693,427 |
209,712,779 |
RGD:6480464 |
CTD |
| G |
Tcf7l2 |
transcription factor 7-like 2 (T-cell specific, HMG-box) |
|
multiple interactions |
ISO |
1 |
262,031,823 |
262,226,710 |
RGD:6480464 |
CTD |
| G |
Tead1 |
TEA domain family member 1 |
|
decreases response to substance |
ISO |
1 |
170,481,601 |
170,696,621 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
increases response to substance |
ISO |
20 |
9,526,674 |
9,530,534 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
affects expression |
ISO |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
decreases response to substance |
ISO |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
multiple interactions |
ISO |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Zfp706 |
zinc finger protein 706 |
|
increases response to substance |
ISO |
7 |
72,511,133 |
72,517,676 |
RGD:6480464 |
CTD |
CTP
|
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
cytarabine
|
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
affects response to substance |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases expression |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
affects response to substance |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Acap1 |
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
|
increases expression |
ISO |
10 |
56,725,173 |
56,727,956 |
RGD:6480464 |
CTD |
| G |
Acta1 |
actin, alpha 1, skeletal muscle |
|
increases expression |
ISO |
19 |
54,081,496 |
54,084,508 |
RGD:6480464 |
CTD |
| G |
Actc1 |
actin, alpha, cardiac muscle 1 |
|
decreases expression |
ISO |
3 |
99,901,022 |
99,906,558 |
RGD:6480464 |
CTD |
| G |
Adam19 |
ADAM metallopeptidase domain 19 |
|
decreases expression |
ISO |
10 |
31,190,242 |
31,282,773 |
RGD:6480464 |
CTD |
| G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
decreases expression |
ISO |
11 |
25,434,262 |
25,443,144 |
RGD:6480464 |
CTD |
| G |
Adamts9 |
ADAM metallopeptidase with thrombospondin type 1 motif, 9 |
|
decreases expression |
ISO |
4 |
126,996,604 |
127,198,909 |
RGD:6480464 |
CTD |
| G |
Afap1l2 |
actin filament associated protein 1-like 2 |
|
decreases expression |
ISO |
1 |
263,220,056 |
263,256,132 |
RGD:6480464 |
CTD |
| G |
Ahnak |
AHNAK nucleoprotein |
|
decreases expression |
ISO |
1 |
211,662,523 |
211,692,558 |
RGD:6480464 |
CTD |
| G |
Aif1l |
allograft inflammatory factor 1-like |
|
increases expression |
ISO |
3 |
11,053,196 |
11,078,079 |
RGD:6480464 |
CTD |
| G |
Alpk2 |
alpha-kinase 2 |
|
decreases expression |
ISO |
18 |
61,562,696 |
61,587,804 |
RGD:6480464 |
CTD |
| G |
Angptl2 |
angiopoietin-like 2 |
|
decreases expression |
ISO |
3 |
12,226,515 |
12,256,396 |
RGD:6480464 |
CTD |
| G |
Anks1a |
ankyrin repeat and sterile alpha motif domain containing 1A |
|
decreases expression |
ISO |
20 |
6,121,316 |
6,274,822 |
RGD:6480464 |
CTD |
| G |
Ano8 |
anoctamin 8 |
|
increases expression |
ISO |
16 |
18,646,561 |
18,656,780 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
decreases expression |
ISO |
8 |
73,897,618 |
73,934,041 |
RGD:6480464 |
CTD |
| G |
Anxa6 |
annexin A6 |
|
decreases expression |
ISO |
10 |
40,383,975 |
40,439,683 |
RGD:6480464 |
CTD |
| G |
Anxa8 |
annexin A8 |
|
decreases expression |
ISO |
16 |
9,715,644 |
9,730,584 |
RGD:6480464 |
CTD |
| G |
Aplnr |
apelin receptor |
|
decreases expression |
ISO |
3 |
68,365,637 |
68,369,282 |
RGD:6480464 |
CTD |
| G |
Apobec3b |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B |
|
increases expression |
ISO |
7 |
118,121,580 |
118,140,691 |
RGD:6480464 |
CTD |
| G |
Aqp1 |
aquaporin 1 |
|
decreases expression |
ISO |
4 |
84,098,346 |
84,110,524 |
RGD:6480464 |
CTD |
| G |
Arg2 |
arginase type II |
|
decreases expression |
ISO |
6 |
101,901,653 |
101,928,282 |
RGD:6480464 |
CTD |
| G |
Arhgap44 |
Rho GTPase activating protein 44 |
|
decreases expression |
ISO |
10 |
51,313,035 |
51,479,556 |
RGD:6480464 |
CTD |
| G |
Arhgdib |
Rho, GDP dissociation inhibitor (GDI) beta |
|
decreases expression |
ISO |
4 |
173,967,842 |
173,986,494 |
RGD:6480464 |
CTD |
| G |
Arhgef3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
|
decreases expression |
ISO |
16 |
2,595,636 |
2,665,051 |
RGD:6480464 |
CTD |
| G |
Arl6ip5 |
ADP-ribosylation-like factor 6 interacting protein 5 |
|
increases expression |
ISO |
4 |
131,929,503 |
131,953,033 |
RGD:6480464 |
CTD |
| G |
Art4 |
ADP-ribosyltransferase 4 (Dombrock blood group) |
|
decreases expression |
ISO |
4 |
173,884,317 |
173,893,756 |
RGD:6480464 |
CTD |
| G |
Art5 |
ADP-ribosyltransferase 5 |
|
decreases expression |
ISO |
1 |
159,576,990 |
159,586,949 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
decreases expression |
ISO |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atl1 |
atlastin GTPase 1 |
|
increases expression |
ISO |
6 |
91,979,260 |
92,077,664 |
RGD:6480464 |
CTD |
| G |
Atn1 |
atrophin 1 |
|
increases expression |
ISO |
4 |
160,872,360 |
160,886,205 |
RGD:6480464 |
CTD |
| G |
Atp10d |
ATPase, class V, type 10D |
|
increases expression |
ISO |
14 |
38,340,037 |
38,433,736 |
RGD:6480464 |
CTD |
| G |
Atp1b1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
|
decreases expression |
ISO |
13 |
80,214,056 |
80,234,576 |
RGD:6480464 |
CTD |
| G |
Atp7b |
ATPase, Cu++ transporting, beta polypeptide |
|
decreases expression |
ISO |
16 |
74,607,988 |
74,680,080 |
RGD:6480464 |
CTD |
| G |
Atp8b4 |
ATPase, class I, type 8B, member 4 |
|
decreases expression |
ISO |
3 |
113,781,099 |
113,943,532 |
RGD:6480464 |
CTD |
| G |
Axl |
Axl receptor tyrosine kinase |
|
decreases expression |
ISO |
1 |
80,964,751 |
80,994,300 |
RGD:6480464 |
CTD |
| G |
B2m |
beta-2 microglobulin |
|
increases expression |
ISO |
3 |
108,927,919 |
108,932,718 |
RGD:6480464 |
CTD |
| G |
B4galt7 |
xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 |
|
decreases expression |
ISO |
17 |
15,059,958 |
15,068,556 |
RGD:6480464 |
CTD |
| G |
Bag3 |
Bcl2-associated athanogene 3 |
|
decreases expression |
ISO |
1 |
187,781,147 |
187,804,835 |
RGD:6480464 |
CTD |
| G |
Bai3 |
brain-specific angiogenesis inhibitor 3 |
|
increases expression |
ISO |
9 |
23,759,340 |
24,495,409 |
RGD:6480464 |
CTD |
| G |
Baiap2l1 |
BAI1-associated protein 2-like 1 |
|
decreases expression |
ISO |
12 |
10,584,749 |
10,668,948 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcar3 |
breast cancer anti-estrogen resistance 3 |
|
decreases expression |
ISO |
2 |
219,075,206 |
219,188,344 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases degradation |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bhlhe22 |
basic helix-loop-helix family, member e22 |
|
increases expression |
ISO |
2 |
103,086,407 |
103,089,400 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
multiple interactions |
ISO |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Bin2 |
bridging integrator 2 |
|
increases expression |
ISO |
7 |
139,408,145 |
139,434,350 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
decreases expression |
ISO |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
Bmp5 |
bone morphogenetic protein 5 |
|
decreases expression |
ISO |
8 |
80,593,053 |
80,717,015 |
RGD:6480464 |
CTD |
| G |
Bnc1 |
basonuclin 1 |
|
decreases expression |
ISO |
1 |
138,189,334 |
138,201,795 |
RGD:6480464 |
CTD |
| G |
Bnc2 |
basonuclin 2 |
|
decreases expression |
ISO |
5 |
103,143,810 |
103,474,243 |
RGD:6480464 |
CTD |
| G |
Bora |
bora, aurora kinase A activator |
|
decreases expression |
ISO |
15 |
82,829,209 |
82,852,061 |
RGD:6480464 |
CTD |
| G |
Brca2 |
breast cancer 2, early onset |
|
increases expression |
ISO |
12 |
4,282,952 |
4,323,693 |
RGD:6480464 |
CTD |
| G |
Bscl2 |
Berardinelli-Seip congenital lipodystrophy 2 (seipin) |
|
increases expression |
ISO |
1 |
211,509,675 |
211,518,963 |
RGD:6480464 |
CTD |
| G |
Bst2 |
bone marrow stromal cell antigen 2 |
|
decreases expression |
ISO |
16 |
18,698,545 |
18,701,768 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
increases expression |
ISO |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
C2cd2 |
C2 calcium-dependent domain containing 2 |
|
decreases expression |
ISO |
11 |
37,873,369 |
37,935,054 |
RGD:6480464 |
CTD |
| G |
C3ar1 |
complement component 3a receptor 1 |
|
increases expression |
ISO |
4 |
159,326,402 |
159,333,433 |
RGD:6480464 |
CTD |
| G |
Cab39l |
calcium binding protein 39-like |
|
decreases expression |
ISO |
15 |
38,552,234 |
38,640,594 |
RGD:6480464 |
CTD |
| G |
Calb1 |
calbindin 1 |
|
decreases expression |
EXP |
5 |
30,455,665 |
30,480,122 |
RGD:6480464 |
CTD |
| G |
Calb2 |
calbindin 2 |
|
decreases expression |
ISO |
19 |
40,023,072 |
40,051,150 |
RGD:6480464 |
CTD |
| G |
Calcr |
calcitonin receptor |
|
increases response to substance |
ISO |
4 |
28,486,176 |
28,561,296 |
RGD:6480464 |
CTD |
| G |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
|
increases expression |
ISO |
5 |
157,235,534 |
157,237,314 |
RGD:6480464 |
CTD |
| G |
Capn1 |
calpain 1, (mu/I) large subunit |
|
decreases expression |
ISO |
1 |
208,620,286 |
208,645,007 |
RGD:6480464 |
CTD |
| G |
Car12 |
carbonic anyhydrase 12 |
|
decreases expression |
ISO |
8 |
71,017,732 |
71,070,729 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Ccdc102a |
coiled-coil domain containing 102A |
|
decreases expression |
ISO |
19 |
10,540,236 |
10,558,485 |
RGD:6480464 |
CTD |
| G |
Ccdc112 |
coiled-coil domain containing 112 |
|
increases expression |
ISO |
18 |
40,455,513 |
40,489,699 |
RGD:6480464 |
CTD |
| G |
Ccdc15 |
coiled-coil domain containing 15 |
|
increases expression |
ISO |
8 |
38,534,697 |
38,603,744 |
RGD:6480464 |
CTD |
| G |
Cckbr |
cholecystokinin B receptor |
|
decreases expression |
ISO |
1 |
163,156,914 |
163,166,969 |
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccne2 |
cyclin E2 |
|
increases expression |
ISO |
5 |
25,032,748 |
25,044,509 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
EXP |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
EXP |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
decreases expression |
ISO |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cd8a |
CD8a molecule |
|
increases expression |
ISO |
4 |
104,589,922 |
104,594,159 |
RGD:6480464 |
CTD |
| G |
Cdc42ep5 |
CDC42 effector protein (Rho GTPase binding) 5 |
|
decreases expression |
ISO |
1 |
69,449,412 |
69,449,936 |
RGD:6480464 |
CTD |
| G |
Cdca8 |
cell division cycle associated 8 |
|
decreases expression |
ISO |
5 |
144,251,164 |
144,276,352 |
RGD:6480464 |
CTD |
| G |
Cdh11 |
cadherin 11 |
|
decreases expression |
ISO |
19 |
2,225,209 |
2,382,805 |
RGD:6480464 |
CTD |
| G |
Cdh3 |
cadherin 3 |
|
decreases expression |
ISO |
19 |
36,343,823 |
36,393,819 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
decreases expression |
ISO |
1 |
203,835,215 |
203,837,844 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Celf3 |
CUGBP, Elav-like family member 3 |
|
increases expression |
ISO |
2 |
189,451,415 |
189,465,513 |
RGD:6480464 |
CTD |
| G |
Chat |
choline O-acetyltransferase |
|
increases activity |
EXP |
16 |
7,913,026 |
7,965,985 |
RGD:6480464 |
CTD |
| G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
decreases expression |
ISO |
1 |
12,721,500 |
12,723,943 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
increases expression |
ISO |
6 |
136,452,215 |
136,455,122 |
RGD:6480464 |
CTD |
| G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
|
decreases expression |
ISO |
17 |
19,423,502 |
19,429,451 |
RGD:6480464 |
CTD |
| G |
Cldn15 |
claudin 15 |
|
decreases expression |
ISO |
12 |
20,823,334 |
20,845,306 |
RGD:6480464 |
CTD |
| G |
Clec1b |
C-type lectin domain family 1, member B |
|
decreases expression |
ISO |
4 |
166,671,432 |
166,679,641 |
RGD:6480464 |
CTD |
| G |
Cnih2 |
cornichon homolog 2 (Drosophila) |
|
increases expression |
ISO |
1 |
207,715,692 |
207,717,588 |
RGD:6480464 |
CTD |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
increases expression |
ISO |
5 |
50,427,173 |
50,445,471 |
RGD:6480464 |
CTD |
| G |
Cntfr |
ciliary neurotrophic factor receptor |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cntrl |
centriolin |
|
increases expression |
ISO |
3 |
14,168,983 |
14,242,139 |
RGD:6480464 |
CTD |
| G |
Cobll1 |
cordon-bleu WH2 repeat protein-like 1 |
|
decreases expression |
ISO |
3 |
47,024,613 |
47,035,010 |
RGD:6480464 |
CTD |
| G |
Col13a1 |
collagen, type XIII, alpha 1 |
|
decreases expression |
ISO |
20 |
29,208,654 |
29,348,751 |
RGD:6480464 |
CTD |
| G |
Col18a1 |
collagen, type XVIII, alpha 1 |
|
decreases expression |
ISO |
20 |
11,920,816 |
11,982,468 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
decreases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
decreases expression |
ISO |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col5a1 |
collagen, type V, alpha 1 |
|
decreases expression |
ISO |
3 |
6,826,169 |
6,971,054 |
RGD:6480464 |
CTD |
| G |
Col5a2 |
collagen, type V, alpha 2 |
|
decreases expression |
ISO |
9 |
44,374,113 |
44,525,086 |
RGD:6480464 |
CTD |
| G |
Col6a2 |
collagen, type VI, alpha 2 |
|
decreases expression |
ISO |
20 |
12,436,783 |
12,464,512 |
RGD:6480464 |
CTD |
| G |
Col6a3 |
collagen, type VI, alpha 3 |
|
decreases expression |
ISO |
9 |
89,990,129 |
90,043,697 |
RGD:6480464 |
CTD |
| G |
Col9a1 |
collagen, type IX, alpha 1 |
|
increases expression |
ISO |
9 |
22,907,157 |
22,990,836 |
RGD:6480464 |
CTD |
| G |
Colec12 |
collectin sub-family member 12 |
|
decreases expression |
ISO |
18 |
996,297 |
1,188,288 |
RGD:6480464 |
CTD |
| G |
Cpz |
carboxypeptidase Z |
|
decreases expression |
ISO |
14 |
80,857,371 |
80,880,592 |
RGD:6480464 |
CTD |
| G |
Crabp1 |
cellular retinoic acid binding protein 1 |
|
increases expression |
ISO |
8 |
58,317,337 |
58,325,375 |
RGD:6480464 |
CTD |
| G |
Crispld2 |
cysteine-rich secretory protein LCCL domain containing 2 |
|
decreases expression |
ISO |
19 |
50,313,710 |
50,378,031 |
RGD:6480464 |
CTD |
| G |
Crtap |
cartilage associated protein |
|
decreases expression |
ISO |
8 |
118,765,925 |
118,773,673 |
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
decreases expression |
ISO |
8 |
54,107,824 |
54,111,502 |
RGD:6480464 |
CTD |
| G |
Csnk1d |
casein kinase 1, delta |
|
decreases expression |
ISO |
10 |
110,166,244 |
110,197,233 |
RGD:6480464 |
CTD |
| G |
Ctsh |
cathepsin H |
|
decreases expression |
ISO |
8 |
94,971,689 |
94,990,434 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
decreases expression |
ISO |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
increases expression |
ISO |
13 |
41,308,286 |
41,312,190 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
increases expression |
ISO |
13 |
41,308,286 |
41,312,190 |
RGD:6480464 |
CTD |
| G |
Cyb5a |
cytochrome b5 type A (microsomal) |
|
decreases expression |
ISO |
18 |
81,415,972 |
81,452,606 |
RGD:6480464 |
CTD |
| G |
Cyb5d1 |
cytochrome b5 domain containing 1 |
|
decreases expression |
ISO |
10 |
56,188,328 |
56,189,804 |
RGD:6480464 |
CTD |
| G |
Cyb5r2 |
cytochrome b5 reductase 2 |
|
decreases expression |
ISO |
1 |
165,131,106 |
165,139,340 |
RGD:6480464 |
CTD |
| G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
decreases expression |
ISO |
19 |
52,713,150 |
52,721,609 |
RGD:6480464 |
CTD |
| G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
9 |
74,039,204 |
74,068,648 |
RGD:6480464 |
CTD |
| G |
Cyp4x1 |
cytochrome P450, family 4, subfamily x, polypeptide 1 |
|
decreases expression |
ISO |
5 |
135,496,568 |
135,527,509 |
RGD:6480464 |
CTD |
| G |
Cyth1 |
cytohesin 1 |
|
increases expression |
ISO |
10 |
108,189,311 |
108,253,419 |
RGD:6480464 |
CTD |
| G |
Dalrd3 |
DALR anticodon binding domain containing 3 |
|
decreases expression |
ISO |
8 |
113,615,939 |
113,618,815 |
RGD:6480464 |
CTD |
| G |
Dbn1 |
drebrin 1 |
|
decreases expression |
ISO |
17 |
15,194,687 |
15,208,660 |
RGD:6480464 |
CTD |
| G |
Dck |
deoxycytidine kinase |
|
affects binding |
ISO |
14 |
20,886,700 |
20,904,305 |
RGD:6480464 |
CTD |
| G |
Dck |
deoxycytidine kinase |
|
decreases response to substance |
ISO |
14 |
20,886,700 |
20,904,305 |
RGD:6480464 |
CTD |
| G |
Dcn |
decorin |
|
decreases expression |
ISO |
7 |
35,004,234 |
35,045,191 |
RGD:6480464 |
CTD |
| G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
|
decreases expression |
ISO |
13 |
85,801,449 |
85,846,636 |
RGD:6480464 |
CTD |
| G |
Dennd1a |
DENN/MADD domain containing 1A |
|
increases expression |
ISO |
3 |
17,561,878 |
17,996,342 |
RGD:6480464 |
CTD |
| G |
Dhcr24 |
24-dehydrocholesterol reductase |
|
decreases expression |
ISO |
5 |
127,637,438 |
127,662,621 |
RGD:6480464 |
CTD |
| G |
Dhfr |
dihydrofolate reductase |
|
increases expression |
ISO |
2 |
22,607,093 |
22,828,487 |
RGD:6480464 |
CTD |
| G |
Dnah2 |
dynein, axonemal, heavy chain 2 |
|
decreases expression |
ISO |
10 |
56,211,207 |
56,364,017 |
RGD:6480464 |
CTD |
| G |
Dok4 |
docking protein 4 |
|
decreases expression |
ISO |
19 |
10,585,647 |
10,596,322 |
RGD:6480464 |
CTD |
| G |
Dsc2 |
desmocollin 2 |
|
decreases expression |
ISO |
18 |
11,902,185 |
11,933,989 |
RGD:6480464 |
CTD |
| G |
Dsc3 |
desmocollin 3 |
|
decreases expression |
ISO |
18 |
11,831,071 |
11,865,107 |
RGD:6480464 |
CTD |
| G |
Dusp4 |
dual specificity phosphatase 4 |
|
decreases expression |
ISO |
16 |
61,109,626 |
61,119,981 |
RGD:6480464 |
CTD |
| G |
Eef2 |
eukaryotic translation elongation factor 2 |
|
decreases expression |
ISO |
7 |
10,017,061 |
10,022,331 |
RGD:6480464 |
CTD |
| G |
Efhd1 |
EF-hand domain family, member D1 |
|
decreases expression |
ISO |
9 |
86,076,009 |
86,124,552 |
RGD:6480464 |
CTD |
| G |
Efna1 |
ephrin A1 |
|
decreases expression |
ISO |
2 |
181,444,599 |
181,451,944 |
RGD:6480464 |
CTD |
| G |
Egfem1 |
EGF-like and EMI domain containing 1 |
|
increases expression |
ISO |
2 |
113,748,239 |
114,345,992 |
RGD:6480464 |
CTD |
| G |
Egfl6 |
EGF-like-domain, multiple 6 |
|
decreases expression |
ISO |
X |
48,568,644 |
48,626,802 |
RGD:6480464 |
CTD |
| G |
Egflam |
EGF-like, fibronectin type III and laminin G domains |
|
decreases expression |
ISO |
2 |
56,493,064 |
56,666,659 |
RGD:6480464 |
CTD |
| G |
Eif4h |
eukaryotic translation initiation factor 4H |
|
decreases expression |
ISO |
12 |
23,148,332 |
23,164,980 |
RGD:6480464 |
CTD |
| G |
Eno3 |
enolase 3, beta, muscle |
|
decreases expression |
ISO |
10 |
57,536,965 |
57,542,317 |
RGD:6480464 |
CTD |
| G |
Entpd1 |
ectonucleoside triphosphate diphosphohydrolase 1 |
|
increases expression |
ISO |
1 |
245,783,750 |
245,887,419 |
RGD:6480464 |
CTD |
| G |
Exog |
endo/exonuclease (5'-3'), endonuclease G-like |
|
decreases expression |
ISO |
8 |
124,410,416 |
124,430,163 |
RGD:6480464 |
CTD |
| G |
Ext2 |
exostosin glycosyltransferase 2 |
|
decreases expression |
ISO |
3 |
78,111,436 |
78,244,444 |
RGD:6480464 |
CTD |
| G |
Ezr |
ezrin |
|
decreases expression |
ISO |
1 |
41,178,195 |
41,221,735 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
affects expression |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
Fabp7 |
fatty acid binding protein 7, brain |
|
increases expression |
ISO |
20 |
36,812,518 |
36,816,050 |
RGD:6480464 |
CTD |
| G |
Fam111a |
family with sequence similarity 111, member A |
|
increases expression |
ISO |
1 |
215,581,410 |
215,597,220 |
RGD:6480464 |
CTD |
| G |
Fam129b |
family with sequence similarity 129, member B |
|
decreases expression |
ISO |
3 |
11,862,604 |
11,912,117 |
RGD:6480464 |
CTD |
| G |
Fam188b |
family with sequence similarity 188, member B |
|
decreases expression |
ISO |
4 |
83,974,751 |
84,079,264 |
RGD:6480464 |
CTD |
| G |
Fam46a |
family with sequence similarity 46, member A |
|
decreases expression |
ISO |
8 |
90,502,441 |
90,506,129 |
RGD:6480464 |
CTD |
| G |
Fam46c |
family with sequence similarity 46, member C |
|
decreases expression |
ISO |
2 |
195,462,849 |
195,481,953 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
increases expression |
EXP |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
increases expression |
EXP |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fbln1 |
fibulin 1 |
|
decreases expression |
ISO |
7 |
123,208,154 |
123,287,289 |
RGD:6480464 |
CTD |
| G |
Fbxo2 |
F-box protein 2 |
|
decreases expression |
ISO |
5 |
165,239,080 |
165,244,509 |
RGD:6480464 |
CTD |
| G |
Fcgr2a |
Fc fragment of IgG, low affinity IIa, receptor |
|
increases expression |
ISO |
13 |
86,898,651 |
86,911,743 |
RGD:6480464 |
CTD |
| G |
Flnc |
filamin C, gamma |
|
decreases expression |
ISO |
4 |
56,313,707 |
56,341,400 |
RGD:6480464 |
CTD |
| G |
Flrt2 |
fibronectin leucine rich transmembrane protein 2 |
|
decreases expression |
ISO |
6 |
119,569,366 |
119,658,949 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
decreases expression |
ISO |
13 |
78,503,770 |
78,536,359 |
RGD:6480464 |
CTD |
| G |
Fmo4 |
flavin containing monooxygenase 4 |
|
decreases expression |
ISO |
13 |
78,476,211 |
78,494,458 |
RGD:6480464 |
CTD |
| G |
Frzb |
frizzled-related protein |
|
decreases expression |
ISO |
3 |
63,350,504 |
63,383,436 |
RGD:6480464 |
CTD |
| G |
Fsip1 |
fibrous sheath interacting protein 1 |
|
increases expression |
ISO |
3 |
104,629,182 |
104,680,197 |
RGD:6480464 |
CTD |
| G |
Fyn |
FYN oncogene related to SRC, FGR, YES |
|
increases expression |
ISO |
20 |
43,501,853 |
43,695,567 |
RGD:6480464 |
CTD |
| G |
Gabarapl1 |
GABA(A) receptor-associated protein like 1 |
|
decreases expression |
ISO |
4 |
166,802,106 |
166,811,249 |
RGD:6480464 |
CTD |
| G |
Gabrp |
gamma-aminobutyric acid (GABA-A) receptor, pi |
|
increases expression |
ISO |
10 |
18,454,555 |
18,474,564 |
RGD:6480464 |
CTD |
| G |
Galnt10 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (GalNAc-T10) |
|
decreases expression |
ISO |
10 |
43,237,411 |
43,381,584 |
RGD:6480464 |
CTD |
| G |
Gap43 |
growth associated protein 43 |
|
increases expression |
ISO |
11 |
59,989,085 |
60,083,971 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
decreases activity |
ISO |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
increases response to substance |
ISO |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
affects localization |
ISO |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Gata5 |
GATA binding protein 5 |
|
decreases expression |
ISO |
3 |
169,385,321 |
169,393,508 |
RGD:6480464 |
CTD |
| G |
Gbp4 |
guanylate binding protein 4 |
|
decreases expression |
ISO |
2 |
240,495,963 |
240,509,393 |
RGD:6480464 |
CTD |
| G |
Gca |
grancalcin |
|
decreases expression |
ISO |
3 |
44,616,037 |
44,648,897 |
RGD:6480464 |
CTD |
| G |
Gcnt2 |
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme |
|
decreases expression |
ISO |
17 |
29,767,383 |
29,808,950 |
RGD:6480464 |
CTD |
| G |
Ghr |
growth hormone receptor |
|
decreases expression |
ISO |
2 |
52,496,517 |
52,658,066 |
RGD:6480464 |
CTD |
| G |
Gls |
glutaminase |
|
decreases expression |
ISO |
9 |
46,380,165 |
46,452,974 |
RGD:6480464 |
CTD |
| G |
Gnb3 |
guanine nucleotide binding protein (G protein), beta polypeptide 3 |
|
decreases expression |
ISO |
4 |
160,957,524 |
160,963,226 |
RGD:6480464 |
CTD |
| G |
Gper |
G protein-coupled estrogen receptor 1 |
|
decreases expression |
ISO |
12 |
15,718,615 |
15,719,893 |
RGD:6480464 |
CTD |
| G |
Gpm6a |
glycoprotein m6a |
|
increases expression |
ISO |
16 |
39,670,748 |
39,783,384 |
RGD:6480464 |
CTD |
| G |
Gpr19 |
G protein-coupled receptor 19 |
|
increases expression |
ISO |
4 |
171,791,727 |
171,809,215 |
RGD:6480464 |
CTD |
| G |
Gpr83 |
G protein-coupled receptor 83 |
|
decreases expression |
ISO |
8 |
11,648,755 |
11,659,242 |
RGD:6480464 |
CTD |
| G |
Gprc5c |
G protein-coupled receptor, family C, group 5, member C |
|
decreases expression |
ISO |
10 |
104,731,909 |
104,754,468 |
RGD:6480464 |
CTD |
| G |
Gria2 |
glutamate receptor, ionotropic, AMPA 2 |
|
increases expression |
ISO |
2 |
172,265,155 |
172,385,285 |
RGD:6480464 |
CTD |
| G |
Grk5 |
G protein-coupled receptor kinase 5 |
|
increases expression |
ISO |
1 |
267,495,534 |
267,693,144 |
RGD:6480464 |
CTD |
| G |
Grpr |
gastrin releasing peptide receptor |
|
decreases expression |
ISO |
X |
51,743,248 |
51,783,255 |
RGD:6480464 |
CTD |
| G |
Gstcd |
glutathione S-transferase, C-terminal domain containing |
|
increases expression |
ISO |
2 |
230,514,129 |
230,610,809 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
affects response to substance |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gtpbp1 |
GTP binding protein 1 |
|
increases expression |
ISO |
7 |
117,934,168 |
117,957,660 |
RGD:6480464 |
CTD |
| G |
Gucy1a3 |
guanylate cyclase 1, soluble, alpha 3 |
|
decreases expression |
ISO |
2 |
173,756,824 |
173,818,316 |
RGD:6480464 |
CTD |
| G |
H2afj |
H2A histone family, member J |
|
decreases expression |
ISO |
4 |
173,818,670 |
173,819,154 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
increases phosphorylation |
ISO |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
Hand1 |
heart and neural crest derivatives expressed 1 |
|
decreases expression |
ISO |
10 |
43,423,366 |
43,425,933 |
RGD:6480464 |
CTD |
| G |
Hand2 |
heart and neural crest derivatives expressed 2 |
|
decreases expression |
ISO |
16 |
36,324,327 |
36,348,104 |
RGD:6480464 |
CTD |
| G |
Hapln1 |
hyaluronan and proteoglycan link protein 1 |
|
decreases expression |
ISO |
2 |
19,576,064 |
19,638,106 |
RGD:6480464 |
CTD |
| G |
Has2 |
hyaluronan synthase 2 |
|
decreases expression |
ISO |
7 |
93,230,135 |
93,256,139 |
RGD:6480464 |
CTD |
| G |
Hcfc1r1 |
host cell factor C1 regulator 1 (XPO1-dependent) |
|
decreases expression |
ISO |
10 |
12,938,469 |
12,940,104 |
RGD:6480464 |
CTD |
| G |
Hes5 |
hairy and enhancer of split 5 (Drosophila) |
|
increases expression |
ISO |
5 |
171,763,869 |
171,764,636 |
RGD:6480464 |
CTD |
| G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
|
decreases expression |
ISO |
2 |
193,128,736 |
193,143,106 |
RGD:6480464 |
CTD |
| G |
Hnrnpa3 |
heterogeneous nuclear ribonucleoprotein A3 |
|
decreases expression |
ISO |
3 |
68,872,863 |
68,875,337 |
RGD:6480464 |
CTD |
| G |
Hoxa2 |
homeo box A2 |
|
increases expression |
ISO |
4 |
80,462,651 |
80,464,927 |
RGD:6480464 |
CTD |
| G |
Hoxb4 |
homeo box B4 |
|
decreases expression |
ISO |
10 |
85,050,695 |
85,053,277 |
RGD:6480464 |
CTD |
| G |
Hoxb6 |
homeo box B6 |
|
decreases expression |
ISO |
10 |
85,030,558 |
85,033,604 |
RGD:6480464 |
CTD |
| G |
Hoxb8 |
homeo box B8 |
|
decreases expression |
ISO |
10 |
85,013,711 |
85,015,462 |
RGD:6480464 |
CTD |
| G |
Hs3st1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 1 |
|
decreases expression |
ISO |
14 |
76,438,219 |
76,439,157 |
RGD:6480464 |
CTD |
| G |
Htra1 |
HtrA serine peptidase 1 |
|
decreases expression |
ISO |
1 |
190,257,899 |
190,308,325 |
RGD:6480464 |
CTD |
| G |
Ifit1 |
interferon-induced protein with tetratricopeptide repeats 1 |
|
decreases expression |
ISO |
1 |
238,609,171 |
238,611,236 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
decreases expression |
ISO |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
decreases expression |
ISO |
9 |
72,003,637 |
72,016,263 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Impad1 |
inositol monophosphatase domain containing 1 |
|
decreases expression |
ISO |
5 |
18,086,121 |
18,109,691 |
RGD:6480464 |
CTD |
| G |
Ina |
internexin neuronal intermediate filament protein, alpha |
|
increases expression |
ISO |
1 |
252,328,186 |
252,340,997 |
RGD:6480464 |
CTD |
| G |
Irx5 |
iroquois homeobox 5 |
|
increases expression |
ISO |
19 |
15,747,720 |
15,750,414 |
RGD:6480464 |
CTD |
| G |
Itgb5 |
integrin, beta 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Itm2c |
integral membrane protein 2C |
|
decreases expression |
ISO |
9 |
84,611,756 |
84,625,391 |
RGD:6480464 |
CTD |
| G |
Jam2 |
junctional adhesion molecule 2 |
|
increases expression |
ISO |
11 |
24,310,704 |
24,315,219 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kank4 |
KN motif and ankyrin repeat domains 4 |
|
decreases expression |
ISO |
5 |
119,170,131 |
119,233,181 |
RGD:6480464 |
CTD |
| G |
Kcnn2 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 |
|
decreases expression |
ISO |
18 |
39,560,962 |
39,705,037 |
RGD:6480464 |
CTD |
| G |
Kctd12 |
potassium channel tetramerisation domain containing 12 |
|
decreases expression |
ISO |
15 |
86,986,827 |
86,987,810 |
RGD:6480464 |
CTD |
| G |
Kdelr3 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3 |
|
decreases expression |
ISO |
7 |
117,556,569 |
117,566,504 |
RGD:6480464 |
CTD |
| G |
Kif15 |
kinesin family member 15 |
|
increases expression |
ISO |
8 |
127,694,272 |
127,764,633 |
RGD:6480464 |
CTD |
| G |
Klhl41 |
kelch-like family member 41 |
|
decreases expression |
ISO |
3 |
51,816,016 |
51,829,140 |
RGD:6480464 |
CTD |
| G |
Klk6 |
kallikrein related-peptidase 6 |
|
decreases expression |
ISO |
1 |
94,254,350 |
94,261,500 |
RGD:6480464 |
CTD |
| G |
Kmo |
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) |
|
increases response to substance |
ISO |
13 |
91,363,517 |
91,394,174 |
RGD:6480464 |
CTD |
| G |
Kpna2 |
karyopherin alpha 2 |
|
decreases expression |
ISO |
10 |
96,342,214 |
96,352,613 |
RGD:6480464 |
CTD |
| G |
Krt19 |
keratin 19 |
|
decreases expression |
ISO |
10 |
89,080,953 |
89,085,670 |
RGD:6480464 |
CTD |
| G |
Krt24 |
keratin 24 |
|
decreases expression |
ISO |
10 |
88,180,329 |
88,186,201 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
decreases expression |
ISO |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Kynu |
kynureninase |
|
decreases expression |
ISO |
3 |
24,046,242 |
24,195,898 |
RGD:6480464 |
CTD |
| G |
Lbh |
limb bud and heart development |
|
decreases expression |
ISO |
6 |
22,662,376 |
22,664,667 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
decreases expression |
ISO |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Lhfp |
lipoma HMGIC fusion partner |
|
increases expression |
ISO |
2 |
141,974,792 |
142,183,203 |
RGD:6480464 |
CTD |
| G |
Limch1 |
LIM and calponin homology domains 1 |
|
increases expression |
ISO |
14 |
43,722,254 |
44,049,555 |
RGD:6480464 |
CTD |
| G |
Lmcd1 |
LIM and cysteine-rich domains 1 |
|
decreases expression |
ISO |
4 |
148,071,431 |
148,130,313 |
RGD:6480464 |
CTD |
| G |
LOC100359600 |
karyopherin alpha 2-like |
|
decreases expression |
ISO |
6 |
10,523,393 |
10,524,982 |
RGD:6480464 |
CTD |
| G |
LOC501282 |
similar to lymphocyte antigen 6 complex, locus E ligand |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Lox |
lysyl oxidase |
|
decreases expression |
ISO |
18 |
47,896,674 |
47,970,829 |
RGD:6480464 |
CTD |
| G |
Loxl4 |
lysyl oxidase-like 4 |
|
decreases expression |
ISO |
1 |
248,269,249 |
248,287,588 |
RGD:6480464 |
CTD |
| G |
Lrba |
LPS-responsive vesicle trafficking, beach and anchor containing |
|
decreases expression |
ISO |
2 |
178,257,272 |
178,787,626 |
RGD:6480464 |
CTD |
| G |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
|
increases expression |
ISO |
4 |
128,919,630 |
129,082,488 |
RGD:6480464 |
CTD |
| G |
Lrrc16a |
leucine rich repeat containing 16A |
|
decreases expression |
ISO |
17 |
47,923,987 |
48,206,590 |
RGD:6480464 |
CTD |
| G |
Lrrc32 |
leucine rich repeat containing 32 |
|
decreases expression |
ISO |
1 |
155,760,527 |
155,771,294 |
RGD:6480464 |
CTD |
| G |
Lrrc41 |
leucine rich repeat containing 41 |
|
decreases expression |
ISO |
5 |
136,234,186 |
136,255,107 |
RGD:6480464 |
CTD |
| G |
Lrrn2 |
leucine rich repeat neuronal 2 |
|
decreases expression |
ISO |
13 |
45,835,522 |
45,837,774 |
RGD:6480464 |
CTD |
| G |
Lrrn3 |
leucine rich repeat neuronal 3 |
|
increases expression |
ISO |
6 |
60,745,501 |
60,776,261 |
RGD:6480464 |
CTD |
| G |
Lrrn4 |
leucine rich repeat neuronal 4 |
|
decreases expression |
ISO |
3 |
120,667,859 |
120,678,960 |
RGD:6480464 |
CTD |
| G |
Lum |
lumican |
|
decreases expression |
ISO |
7 |
35,083,480 |
35,090,284 |
RGD:6480464 |
CTD |
| G |
Ly6h |
lymphocyte antigen 6 complex, locus H |
|
decreases expression |
ISO |
7 |
113,510,429 |
113,512,281 |
RGD:6480464 |
CTD |
| G |
Ly75 |
lymphocyte antigen 75 |
|
increases expression |
ISO |
3 |
42,002,053 |
42,088,438 |
RGD:6480464 |
CTD |
| G |
Lyl1 |
lymphoblastic leukemia derived sequence 1 |
|
decreases response to substance |
ISO |
19 |
25,115,234 |
25,118,100 |
RGD:6480464 |
CTD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
decreases expression |
ISO |
5 |
16,933,111 |
17,054,564 |
RGD:6480464 |
CTD |
| G |
Mab21l2 |
mab-21-like 2 (C. elegans) |
|
decreases expression |
ISO |
2 |
178,522,370 |
178,525,454 |
RGD:6480464 |
CTD |
| G |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
|
increases expression |
ISO |
4 |
127,975,386 |
128,597,119 |
RGD:6480464 |
CTD |
| G |
Map2 |
microtubule-associated protein 2 |
|
decreases expression |
ISO |
9 |
65,174,376 |
65,256,003 |
RGD:6480464 |
CTD |
| G |
Map2 |
microtubule-associated protein 2 |
|
increases expression |
ISO |
9 |
65,174,376 |
65,256,003 |
RGD:6480464 |
CTD |
| G |
March3 |
membrane-associated ring finger (C3HC4) 3, E3 ubiquitin protein ligase |
|
decreases expression |
ISO |
18 |
52,530,738 |
52,682,742 |
RGD:6480464 |
CTD |
| G |
Matn2 |
matrilin 2 |
|
decreases expression |
ISO |
7 |
69,715,611 |
69,880,723 |
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mcoln3 |
mucolipin 3 |
|
decreases expression |
ISO |
2 |
244,235,524 |
244,311,845 |
RGD:6480464 |
CTD |
| G |
Mdk |
midkine |
|
decreases expression |
ISO |
3 |
76,309,988 |
76,311,345 |
RGD:6480464 |
CTD |
| G |
Med9 |
mediator complex subunit 9 |
|
decreases expression |
ISO |
10 |
46,274,791 |
46,290,414 |
RGD:6480464 |
CTD |
| G |
Megf10 |
multiple EGF-like domains 10 |
|
increases expression |
ISO |
18 |
52,948,935 |
53,051,823 |
RGD:6480464 |
CTD |
| G |
Meis1 |
Meis homeobox 1 |
|
increases expression |
ISO |
14 |
99,693,567 |
99,832,273 |
RGD:6480464 |
CTD |
| G |
Mertk |
c-mer proto-oncogene tyrosine kinase |
|
decreases expression |
ISO |
3 |
116,308,387 |
116,416,414 |
RGD:6480464 |
CTD |
| G |
Mfap4 |
microfibrillar-associated protein 4 |
|
decreases expression |
ISO |
10 |
47,646,157 |
47,649,095 |
RGD:6480464 |
CTD |
| G |
Mgarp |
mitochondria-localized glutamic acid-rich protein |
|
decreases expression |
ISO |
2 |
140,282,230 |
140,290,372 |
RGD:6480464 |
CTD |
| G |
Mgp |
matrix Gla protein |
|
decreases expression |
ISO |
4 |
173,910,595 |
173,913,917 |
RGD:6480464 |
CTD |
| G |
Mll |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) |
|
increases response to substance |
ISO |
8 |
47,759,175 |
47,834,586 |
RGD:6480464 |
CTD |
| G |
Mmp23 |
matrix metallopeptidase 23 |
|
decreases expression |
ISO |
5 |
172,486,916 |
172,489,459 |
RGD:6480464 |
CTD |
| G |
Mpp6 |
membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6) |
|
decreases expression |
ISO |
4 |
78,343,494 |
78,424,470 |
RGD:6480464 |
CTD |
| G |
Mpzl1 |
myelin protein zero-like 1 |
|
decreases expression |
ISO |
13 |
81,321,155 |
81,357,929 |
RGD:6480464 |
CTD |
| G |
Msx1 |
msh homeobox 1 |
|
decreases expression |
ISO |
14 |
78,257,345 |
78,261,144 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
decreases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
decreases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
affects response to substance |
ISO |
5 |
165,112,850 |
165,126,885 |
RGD:6480464 |
CTD |
| G |
Mtus1 |
microtubule associated tumor suppressor 1 |
|
increases expression |
ISO |
16 |
54,611,502 |
54,664,075 |
RGD:6480464 |
CTD |
| G |
Mvb12a |
multivesicular body subunit 12A |
|
decreases expression |
ISO |
16 |
18,726,945 |
18,731,772 |
RGD:6480464 |
CTD |
| G |
Mxd3 |
Max dimerization protein 3 |
|
increases expression |
ISO |
17 |
15,346,165 |
15,349,891 |
RGD:6480464 |
CTD |
| G |
Mxra7 |
matrix-remodelling associated 7 |
|
decreases expression |
ISO |
10 |
106,905,636 |
106,921,646 |
RGD:6480464 |
CTD |
| G |
Myadm |
myeloid-associated differentiation marker |
|
decreases expression |
ISO |
1 |
64,177,547 |
64,185,893 |
RGD:6480464 |
CTD |
| G |
Myl4 |
myosin, light chain 4 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Myl7 |
myosin, light chain 7, regulatory |
|
decreases expression |
ISO |
14 |
86,568,142 |
86,570,122 |
RGD:6480464 |
CTD |
| G |
Myof |
myoferlin |
|
decreases expression |
ISO |
1 |
242,209,178 |
242,372,206 |
RGD:6480464 |
CTD |
| G |
Nav2 |
neuron navigator 2 |
|
decreases expression |
ISO |
1 |
99,041,044 |
99,410,077 |
RGD:6480464 |
CTD |
| G |
Ncald |
neurocalcin delta |
|
increases expression |
ISO |
7 |
72,875,314 |
72,976,373 |
RGD:6480464 |
CTD |
| G |
Ndc80 |
NDC80 kinetochore complex component |
|
increases expression |
ISO |
9 |
110,702,935 |
110,718,894 |
RGD:6480464 |
CTD |
| G |
Ndrg1 |
N-myc downstream regulated 1 |
|
decreases expression |
ISO |
7 |
104,302,038 |
104,344,842 |
RGD:6480464 |
CTD |
| G |
Ndrg2 |
NDRG family member 2 |
|
decreases expression |
ISO |
15 |
27,338,552 |
27,347,196 |
RGD:6480464 |
CTD |
| G |
Nell2 |
NEL-like 2 (chicken) |
|
increases expression |
ISO |
7 |
133,758,271 |
134,080,104 |
RGD:6480464 |
CTD |
| G |
Nes |
nestin |
|
increases expression |
ISO |
2 |
180,051,907 |
180,060,947 |
RGD:6480464 |
CTD |
| G |
Nes |
nestin |
|
decreases expression |
ISO |
2 |
180,051,907 |
180,060,947 |
RGD:6480464 |
CTD |
| G |
Nfib |
nuclear factor I/B |
|
increases expression |
ISO |
5 |
101,184,253 |
101,409,907 |
RGD:6480464 |
CTD |
| G |
Nmu |
neuromedin U |
|
increases expression |
ISO |
14 |
34,115,472 |
34,143,662 |
RGD:6480464 |
CTD |
| G |
Nova1 |
neuro-oncological ventral antigen 1 |
|
increases expression |
ISO |
6 |
66,193,472 |
66,320,240 |
RGD:6480464 |
CTD |
| G |
Nox4 |
NADPH oxidase 4 |
|
decreases expression |
ISO |
1 |
143,415,816 |
143,603,554 |
RGD:6480464 |
CTD |
| G |
Nppb |
natriuretic peptide B |
|
increases expression |
ISO |
5 |
165,062,348 |
165,063,650 |
RGD:6480464 |
CTD |
| G |
Nppb |
natriuretic peptide B |
|
increases expression |
ISO |
5 |
165,062,348 |
165,063,650 |
RGD:6480464 |
CTD |
| G |
Npy |
neuropeptide Y |
|
decreases expression |
ISO |
4 |
78,038,013 |
78,045,187 |
RGD:6480464 |
CTD |
| G |
Nrip3 |
nuclear receptor interacting protein 3 |
|
decreases expression |
ISO |
1 |
167,380,328 |
167,405,899 |
RGD:6480464 |
CTD |
| G |
Ntng1 |
netrin G1 |
|
increases expression |
ISO |
2 |
205,438,061 |
205,806,249 |
RGD:6480464 |
CTD |
| G |
Odam |
odontogenic, ameloblast asssociated |
|
decreases expression |
ISO |
14 |
21,714,378 |
21,724,054 |
RGD:6480464 |
CTD |
| G |
Olfml3 |
olfactomedin-like 3 |
|
decreases expression |
ISO |
2 |
198,958,480 |
198,961,309 |
RGD:6480464 |
CTD |
| G |
Olr1 |
oxidized low density lipoprotein (lectin-like) receptor 1 |
|
decreases expression |
ISO |
4 |
166,747,228 |
166,769,340 |
RGD:6480464 |
CTD |
| G |
Osbpl10 |
oxysterol binding protein-like 10 |
|
decreases expression |
ISO |
8 |
119,386,782 |
119,670,147 |
RGD:6480464 |
CTD |
| G |
Osr1 |
odd-skipped related 1 (Drosophila) |
|
decreases expression |
ISO |
6 |
33,074,410 |
33,076,769 |
RGD:6480464 |
CTD |
| G |
P4ha2 |
prolyl 4-hydroxylase, alpha polypeptide II |
|
decreases expression |
ISO |
10 |
39,522,157 |
39,551,063 |
RGD:6480464 |
CTD |
| G |
Pamr1 |
peptidase domain containing associated with muscle regeneration 1 |
|
decreases expression |
ISO |
3 |
87,754,805 |
87,847,008 |
RGD:6480464 |
CTD |
| G |
Pard6a |
par-6 (partitioning defective 6,) homolog alpha (C. elegans) |
|
decreases expression |
ISO |
19 |
35,533,395 |
35,535,711 |
RGD:6480464 |
CTD |
| G |
Parm1 |
prostate androgen-regulated mucin-like protein 1 |
|
decreases expression |
ISO |
14 |
18,045,998 |
18,078,328 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pax6 |
paired box 6 |
|
increases expression |
ISO |
3 |
91,127,605 |
91,149,178 |
RGD:6480464 |
CTD |
| G |
Pax6 |
paired box 6 |
|
decreases expression |
ISO |
3 |
91,127,605 |
91,149,178 |
RGD:6480464 |
CTD |
| G |
Pcdh20 |
protocadherin 20 |
|
decreases expression |
ISO |
15 |
70,760,564 |
70,766,820 |
RGD:6480464 |
CTD |
| G |
Pcdh7 |
protocadherin 7 |
|
decreases expression |
ISO |
14 |
56,609,036 |
57,323,892 |
RGD:6480464 |
CTD |
| G |
Pcsk5 |
proprotein convertase subtilisin/kexin type 5 |
|
decreases expression |
ISO |
1 |
220,961,912 |
221,405,907 |
RGD:6480464 |
CTD |
| G |
Pde1a |
phosphodiesterase 1A, calmodulin-dependent |
|
increases expression |
ISO |
3 |
62,650,092 |
62,928,487 |
RGD:6480464 |
CTD |
| G |
Pde1b |
phosphodiesterase 1B, calmodulin-dependent |
|
increases expression |
ISO |
7 |
142,401,489 |
142,427,626 |
RGD:6480464 |
CTD |
| G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
|
increases expression |
ISO |
5 |
123,158,156 |
123,533,877 |
RGD:6480464 |
CTD |
| G |
Pde6d |
phosphodiesterase 6D, cGMP-specific, rod, delta |
|
decreases expression |
ISO |
9 |
85,307,907 |
85,352,836 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
decreases expression |
ISO |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Pdlim3 |
PDZ and LIM domain 3 |
|
increases expression |
ISO |
16 |
49,637,068 |
49,668,802 |
RGD:6480464 |
CTD |
| G |
Pdpn |
podoplanin |
|
decreases expression |
ISO |
5 |
162,142,251 |
162,175,921 |
RGD:6480464 |
CTD |
| G |
Peli1 |
pellino E3 ubiquitin protein ligase 1 |
|
increases expression |
ISO |
14 |
101,870,272 |
101,924,228 |
RGD:6480464 |
CTD |
| G |
Pfkp |
phosphofructokinase, platelet |
|
decreases expression |
ISO |
17 |
74,760,912 |
74,823,046 |
RGD:6480464 |
CTD |
| G |
Pgm5 |
phosphoglucomutase 5 |
|
decreases expression |
ISO |
1 |
228,107,411 |
228,300,939 |
RGD:6480464 |
CTD |
| G |
Phactr2 |
phosphatase and actin regulator 2 |
|
decreases expression |
ISO |
1 |
7,988,527 |
8,102,667 |
RGD:6480464 |
CTD |
| G |
Phyhipl |
phytanoyl-CoA 2-hydroxylase interacting protein-like |
|
increases expression |
ISO |
20 |
18,815,710 |
18,849,381 |
RGD:6480464 |
CTD |
| G |
Pigh |
phosphatidylinositol glycan anchor biosynthesis, class H |
|
decreases expression |
ISO |
6 |
101,713,237 |
101,722,655 |
RGD:6480464 |
CTD |
| G |
Pitx1 |
paired-like homeodomain 1 |
|
decreases expression |
ISO |
17 |
14,834,144 |
14,840,303 |
RGD:6480464 |
CTD |
| G |
Pitx2 |
paired-like homeodomain 2 |
|
decreases expression |
ISO |
2 |
226,581,170 |
226,601,319 |
RGD:6480464 |
CTD |
| G |
Pkia |
protein kinase (cAMP-dependent, catalytic) inhibitor alpha |
|
decreases expression |
ISO |
2 |
96,524,399 |
96,548,144 |
RGD:6480464 |
CTD |
| G |
Pkp2 |
plakophilin 2 |
|
decreases expression |
ISO |
11 |
86,553,493 |
86,584,425 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
decreases expression |
ISO |
16 |
73,711,323 |
73,736,328 |
RGD:6480464 |
CTD |
| G |
Plcb2 |
phospholipase C, beta 2 |
|
affects localization |
ISO |
3 |
105,203,524 |
105,223,342 |
RGD:6480464 |
CTD |
| G |
Plcb2 |
phospholipase C, beta 2 |
|
multiple interactions |
ISO |
3 |
105,203,524 |
105,223,342 |
RGD:6480464 |
CTD |
| G |
Plch1 |
phospholipase C, eta 1 |
|
increases expression |
ISO |
2 |
153,467,156 |
153,562,651 |
RGD:6480464 |
CTD |
| G |
Pld3 |
phospholipase D family, member 3 |
|
decreases expression |
ISO |
1 |
82,612,833 |
82,624,575 |
RGD:6480464 |
CTD |
| G |
Plekhg3 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
|
decreases expression |
ISO |
6 |
99,157,196 |
99,175,135 |
RGD:6480464 |
CTD |
| G |
Pllp |
plasmolipin |
|
decreases expression |
ISO |
19 |
10,754,737 |
10,776,134 |
RGD:6480464 |
CTD |
| G |
Plod1 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 |
|
decreases expression |
ISO |
5 |
164,987,252 |
165,012,581 |
RGD:6480464 |
CTD |
| G |
Plp1 |
proteolipid protein 1 |
|
increases expression |
ISO |
X |
124,488,627 |
124,503,639 |
RGD:6480464 |
CTD |
| G |
Pltp |
phospholipid transfer protein |
|
decreases expression |
ISO |
3 |
155,871,842 |
155,889,959 |
RGD:6480464 |
CTD |
| G |
Pmel |
premelanosome protein |
|
increases expression |
ISO |
7 |
2,007,882 |
2,018,998 |
RGD:6480464 |
CTD |
| G |
Pmp22 |
peripheral myelin protein 22 |
|
decreases expression |
ISO |
10 |
49,305,835 |
49,335,864 |
RGD:6480464 |
CTD |
| G |
Podxl |
podocalyxin-like |
|
decreases expression |
ISO |
4 |
58,611,904 |
58,658,598 |
RGD:6480464 |
CTD |
| G |
Podxl2 |
podocalyxin-like 2 |
|
increases expression |
ISO |
4 |
122,937,318 |
122,969,158 |
RGD:6480464 |
CTD |
| G |
Postn |
periostin, osteoblast specific factor |
|
decreases expression |
ISO |
2 |
143,537,099 |
143,568,341 |
RGD:6480464 |
CTD |
| G |
Ppic |
peptidylprolyl isomerase C |
|
decreases expression |
ISO |
18 |
48,886,548 |
48,899,154 |
RGD:6480464 |
CTD |
| G |
Ppt2 |
palmitoyl-protein thioesterase 2 |
|
decreases expression |
ISO |
20 |
4,225,630 |
4,234,653 |
RGD:6480464 |
CTD |
| G |
Prc1 |
protein regulator of cytokinesis 1 |
|
decreases expression |
ISO |
1 |
136,112,674 |
136,133,720 |
RGD:6480464 |
CTD |
| G |
Prickle1 |
prickle homolog 1 (Drosophila) |
|
decreases expression |
ISO |
7 |
131,967,220 |
131,986,187 |
RGD:6480464 |
CTD |
| G |
Prkcdbp |
protein kinase C, delta binding protein |
|
decreases expression |
ISO |
1 |
163,212,922 |
163,214,511 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prnp |
prion protein |
|
decreases expression |
ISO |
3 |
119,676,137 |
119,691,507 |
RGD:6480464 |
CTD |
| G |
Prph |
peripherin |
|
decreases expression |
ISO |
7 |
137,836,152 |
137,839,931 |
RGD:6480464 |
CTD |
| G |
Prrc2c |
proline-rich coiled-coil 2C |
|
decreases expression |
ISO |
13 |
78,332,572 |
78,400,635 |
RGD:6480464 |
CTD |
| G |
Prss35 |
protease, serine, 35 |
|
decreases expression |
ISO |
8 |
92,009,530 |
92,025,563 |
RGD:6480464 |
CTD |
| G |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
|
increases expression |
ISO |
16 |
23,194,137 |
23,662,010 |
RGD:6480464 |
CTD |
| G |
Psrc1 |
proline/serine-rich coiled-coil 1 |
|
decreases expression |
ISO |
2 |
203,952,299 |
203,956,742 |
RGD:6480464 |
CTD |
| G |
Pstpip2 |
proline-serine-threonine phosphatase-interacting protein 2 |
|
decreases expression |
ISO |
18 |
74,776,503 |
74,838,255 |
RGD:6480464 |
CTD |
| G |
Ptchd2 |
patched domain containing 2 |
|
increases expression |
ISO |
5 |
165,319,196 |
165,366,774 |
RGD:6480464 |
CTD |
| G |
Pth1r |
parathyroid hormone 1 receptor |
|
decreases expression |
ISO |
8 |
115,099,763 |
115,119,362 |
RGD:6480464 |
CTD |
| G |
Ptprz1 |
protein tyrosine phosphatase, receptor-type, Z polypeptide 1 |
|
increases expression |
ISO |
4 |
49,267,521 |
49,468,692 |
RGD:6480464 |
CTD |
| G |
Ptrf |
polymerase I and transcript release factor |
|
decreases expression |
ISO |
10 |
89,893,481 |
89,905,343 |
RGD:6480464 |
CTD |
| G |
Qprt |
quinolinate phosphoribosyltransferase |
|
decreases expression |
ISO |
1 |
186,358,523 |
186,374,681 |
RGD:6480464 |
CTD |
| G |
Rab5b |
RAB5B, member RAS oncogene family |
|
increases expression |
ISO |
7 |
1,979,776 |
1,998,540 |
RGD:6480464 |
CTD |
| G |
Rabggtb |
Rab geranylgeranyltransferase, beta subunit |
|
decreases expression |
ISO |
2 |
251,852,549 |
251,857,811 |
RGD:6480464 |
CTD |
| G |
Rad23a |
RAD23 homolog A (S. cerevisiae) |
|
decreases expression |
ISO |
19 |
24,971,070 |
24,976,901 |
RGD:6480464 |
CTD |
| G |
Rad51 |
RAD51 homolog (S. cerevisiae) |
|
increases expression |
ISO |
3 |
105,625,265 |
105,650,392 |
RGD:6480464 |
CTD |
| G |
Ramp1 |
receptor (G protein-coupled) activity modifying protein 1 |
|
decreases expression |
ISO |
9 |
90,402,493 |
90,450,038 |
RGD:6480464 |
CTD |
| G |
Rassf2 |
Ras association (RalGDS/AF-6) domain family member 2 |
|
increases expression |
ISO |
3 |
119,735,754 |
119,769,685 |
RGD:6480464 |
CTD |
| G |
Rbm34 |
RNA binding motif protein 34 |
|
decreases expression |
ISO |
19 |
56,864,501 |
56,885,217 |
RGD:6480464 |
CTD |
| G |
Recql5 |
RecQ protein-like 5 |
|
decreases expression |
ISO |
10 |
106,000,185 |
106,039,287 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases activity |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases phosphorylation |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Reln |
reelin |
|
decreases expression |
ISO |
4 |
8,150,873 |
8,609,141 |
RGD:6480464 |
CTD |
| G |
Rerg |
RAS-like, estrogen-regulated, growth-inhibitor |
|
decreases expression |
ISO |
4 |
174,125,313 |
174,140,346 |
RGD:6480464 |
CTD |
| G |
Rexo4 |
REX4, RNA exonuclease 4 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
3 |
5,849,494 |
5,859,824 |
RGD:6480464 |
CTD |
| G |
RGD1305254 |
similar to transmembrane protein 2 |
|
decreases expression |
ISO |
1 |
140,202,914 |
140,360,061 |
RGD:6480464 |
CTD |
| G |
RGD1359529 |
similar to chromosome 1 open reading frame 63 |
|
decreases expression |
ISO |
5 |
153,698,946 |
153,702,685 |
RGD:6480464 |
CTD |
| G |
RGD1564074 |
similar to novel protein |
|
decreases expression |
ISO |
5 |
125,868,775 |
125,992,281 |
RGD:6480464 |
CTD |
| G |
Rgl1 |
ral guanine nucleotide dissociation stimulator,-like 1 |
|
decreases expression |
ISO |
13 |
67,468,218 |
67,754,947 |
RGD:6480464 |
CTD |
| G |
Rgs1 |
regulator of G-protein signaling 1 |
|
decreases expression |
ISO |
13 |
58,121,188 |
58,125,514 |
RGD:6480464 |
CTD |
| G |
Rgs13 |
regulator of G-protein signaling 13 |
|
decreases expression |
ISO |
13 |
58,016,245 |
58,042,762 |
RGD:6480464 |
CTD |
| G |
Rgs20 |
regulator of G-protein signaling 20 |
|
increases expression |
ISO |
5 |
14,737,677 |
14,816,606 |
RGD:6480464 |
CTD |
| G |
Rgs4 |
regulator of G-protein signaling 4 |
|
decreases expression |
ISO |
13 |
85,533,882 |
85,540,173 |
RGD:6480464 |
CTD |
| G |
Rhoc |
ras homolog family member C |
|
decreases expression |
ISO |
2 |
200,048,056 |
200,054,107 |
RGD:6480464 |
CTD |
| G |
Rhpn2 |
rhophilin, Rho GTPase binding protein 2 |
|
decreases expression |
ISO |
1 |
87,853,620 |
87,917,634 |
RGD:6480464 |
CTD |
| G |
Robo3 |
roundabout, axon guidance receptor, homolog 3 (Drosophila) |
|
increases expression |
ISO |
8 |
38,668,913 |
38,683,439 |
RGD:6480464 |
CTD |
| G |
Rpp25 |
ribonuclease P/MRP 25 subunit |
|
decreases expression |
ISO |
8 |
61,248,740 |
61,250,120 |
RGD:6480464 |
CTD |
| G |
Rprml |
reprimo-like |
|
increases expression |
ISO |
10 |
92,804,937 |
92,805,941 |
RGD:6480464 |
CTD |
| G |
Rras |
related RAS viral (r-ras) oncogene homolog |
|
decreases expression |
ISO |
1 |
95,490,730 |
95,495,462 |
RGD:6480464 |
CTD |
| G |
Rrm2 |
ribonucleotide reductase M2 |
|
increases expression |
ISO |
6 |
42,350,541 |
42,356,748 |
RGD:6480464 |
CTD |
| G |
Rspo2 |
R-spondin 2 |
|
decreases expression |
ISO |
7 |
78,826,526 |
78,912,786 |
RGD:6480464 |
CTD |
| G |
Rtn1 |
reticulon 1 |
|
increases expression |
ISO |
6 |
94,397,061 |
94,682,308 |
RGD:6480464 |
CTD |
| G |
Rwdd1 |
RWD domain containing 1 |
|
increases expression |
ISO |
20 |
37,810,012 |
37,817,545 |
RGD:6480464 |
CTD |
| G |
S100a10 |
S100 calcium binding protein A10 |
|
decreases expression |
ISO |
2 |
186,645,674 |
186,654,321 |
RGD:6480464 |
CTD |
| G |
S100a4 |
S100 calcium-binding protein A4 |
|
decreases expression |
ISO |
2 |
182,885,070 |
182,887,380 |
RGD:6480464 |
CTD |
| G |
Sbspon |
somatomedin B and thrombospondin, type 1 domain containing |
|
decreases expression |
ISO |
5 |
2,516,220 |
2,547,152 |
RGD:6480464 |
CTD |
| G |
Scamp5 |
secretory carrier membrane protein 5 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Scyl1 |
SCY1-like 1 (S. cerevisiae) |
|
decreases expression |
ISO |
1 |
208,385,471 |
208,399,265 |
RGD:6480464 |
CTD |
| G |
Sdc4 |
syndecan 4 |
|
decreases expression |
ISO |
3 |
155,446,138 |
155,464,825 |
RGD:6480464 |
CTD |
| G |
Sec14l1 |
SEC14-like 1 (S. cerevisiae) |
|
decreases expression |
ISO |
10 |
107,220,734 |
107,267,940 |
RGD:6480464 |
CTD |
| G |
Selm |
selenoprotein M |
|
decreases expression |
ISO |
14 |
84,157,831 |
84,160,413 |
RGD:6480464 |
CTD |
| G |
Sema5b |
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B |
|
increases expression |
ISO |
11 |
66,944,881 |
67,070,820 |
RGD:6480464 |
CTD |
| G |
Serpina1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
|
increases expression |
ISO |
6 |
127,998,617 |
128,021,719 |
RGD:6480464 |
CTD |
| G |
Serpinb6 |
serpin peptidase inhibitor, clade B (ovalbumin), member 6 |
|
decreases expression |
ISO |
17 |
37,316,389 |
37,335,124 |
RGD:6480464 |
CTD |
| G |
Serpinb9 |
serpin peptidase inhibitor, clade B (ovalbumin), member 9 |
|
decreases expression |
ISO |
17 |
37,780,179 |
37,791,625 |
RGD:6480464 |
CTD |
| G |
Serpinh1 |
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) |
|
decreases expression |
ISO |
1 |
156,666,914 |
156,674,210 |
RGD:6480464 |
CTD |
| G |
Sertad1 |
SERTA domain containing 1 |
|
decreases expression |
ISO |
1 |
82,565,982 |
82,569,250 |
RGD:6480464 |
CTD |
| G |
Sfrp1 |
secreted frizzled-related protein 1 |
|
increases expression |
ISO |
16 |
73,030,458 |
73,067,304 |
RGD:6480464 |
CTD |
| G |
Sfrp2 |
secreted frizzled-related protein 2 |
|
increases expression |
ISO |
2 |
175,479,320 |
175,486,865 |
RGD:6480464 |
CTD |
| G |
Sgip1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
|
increases expression |
ISO |
5 |
123,696,703 |
123,897,989 |
RGD:6480464 |
CTD |
| G |
Sh3rf2 |
SH3 domain containing ring finger 2 |
|
decreases expression |
ISO |
18 |
35,242,898 |
35,344,485 |
RGD:6480464 |
CTD |
| G |
Sipa1l2 |
signal-induced proliferation-associated 1 like 2 |
|
decreases expression |
ISO |
19 |
55,622,546 |
55,775,008 |
RGD:6480464 |
CTD |
| G |
Sla |
src-like adaptor |
|
increases expression |
ISO |
7 |
104,153,028 |
104,202,272 |
RGD:6480464 |
CTD |
| G |
Slc16a3 |
solute carrier family 16, member 3 (monocarboxylic acid transporter 4) |
|
decreases expression |
ISO |
10 |
110,159,679 |
110,163,182 |
RGD:6480464 |
CTD |
| G |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
|
increases expression |
ISO |
1 |
101,425,975 |
101,466,023 |
RGD:6480464 |
CTD |
| G |
Slc28a1 |
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
|
multiple interactions |
ISO |
1 |
137,323,995 |
137,365,983 |
RGD:6480464 |
CTD |
| G |
Slc28a1 |
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
|
multiple interactions |
EXP |
1 |
137,323,995 |
137,365,983 |
RGD:6480464 |
CTD |
| G |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
decreases response to substance |
ISO |
9 |
11,000,054 |
11,014,914 |
RGD:6480464 |
CTD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
decreases expression |
ISO |
5 |
139,690,801 |
139,719,021 |
RGD:6480464 |
CTD |
| G |
Slc39a2 |
solute carrier family 39 (zinc transporter), member 2 |
|
decreases expression |
ISO |
15 |
27,328,308 |
27,330,420 |
RGD:6480464 |
CTD |
| G |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
|
decreases expression |
ISO |
9 |
44,977,430 |
44,995,358 |
RGD:6480464 |
CTD |
| G |
Slc43a3 |
solute carrier family 43, member 3 |
|
increases expression |
ISO |
3 |
68,152,750 |
68,173,186 |
RGD:6480464 |
CTD |
| G |
Slc47a1 |
solute carrier family 47, member 1 |
|
decreases expression |
ISO |
10 |
47,514,258 |
47,548,353 |
RGD:6480464 |
CTD |
| G |
Slc4a8 |
solute carrier family 4, sodium bicarbonate cotransporter, member 8 |
|
decreases expression |
ISO |
7 |
139,230,085 |
139,575,631 |
RGD:6480464 |
CTD |
| G |
Slc5a12 |
solute carrier family 5 (sodium/glucose cotransporter), member 12 |
|
decreases expression |
ISO |
3 |
96,062,388 |
96,113,699 |
RGD:6480464 |
CTD |
| G |
Slc7a2 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
|
decreases expression |
ISO |
16 |
54,752,119 |
54,805,406 |
RGD:6480464 |
CTD |
| G |
Slc7a7 |
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
|
decreases expression |
ISO |
15 |
32,431,748 |
32,471,526 |
RGD:6480464 |
CTD |
| G |
Slc9a3r1 |
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1 |
|
decreases expression |
ISO |
10 |
105,237,637 |
105,254,750 |
RGD:6480464 |
CTD |
| G |
Slit2 |
slit homolog 2 (Drosophila) |
|
decreases expression |
ISO |
14 |
67,546,283 |
67,891,840 |
RGD:6480464 |
CTD |
| G |
Slitrk3 |
SLIT and NTRK-like family, member 3 |
|
decreases expression |
ISO |
2 |
163,703,843 |
163,711,895 |
RGD:6480464 |
CTD |
| G |
Slitrk5 |
SLIT and NTRK-like family, member 5 |
|
decreases expression |
ISO |
15 |
96,407,553 |
96,412,374 |
RGD:6480464 |
CTD |
| G |
Smad6 |
SMAD family member 6 |
|
decreases expression |
ISO |
8 |
68,144,395 |
68,214,652 |
RGD:6480464 |
CTD |
| G |
Smoc2 |
SPARC related modular calcium binding 2 |
|
decreases expression |
ISO |
1 |
53,165,792 |
53,295,145 |
RGD:6480464 |
CTD |
| G |
Smpdl3a |
sphingomyelin phosphodiesterase, acid-like 3A |
|
decreases expression |
ISO |
20 |
36,821,916 |
36,844,891 |
RGD:6480464 |
CTD |
| G |
Snai2 |
snail homolog 2 (Drosophila) |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Snap91 |
synaptosomal-associated protein 91 |
|
increases expression |
ISO |
8 |
92,033,425 |
92,147,091 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
multiple interactions |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snd1 |
staphylococcal nuclease and tudor domain containing 1 |
|
decreases expression |
ISO |
4 |
55,350,745 |
55,761,185 |
RGD:6480464 |
CTD |
| G |
Snf8 |
SNF8, ESCRT-II complex subunit, homolog (S. cerevisiae) |
|
decreases expression |
ISO |
10 |
84,749,033 |
84,761,230 |
RGD:6480464 |
CTD |
| G |
Sorbs2 |
sorbin and SH3 domain containing 2 |
|
increases expression |
ISO |
16 |
49,722,539 |
49,917,550 |
RGD:6480464 |
CTD |
| G |
Spag16 |
sperm associated antigen 16 |
|
increases expression |
ISO |
9 |
68,853,232 |
69,738,268 |
RGD:6480464 |
CTD |
| G |
Sparc |
secreted protein, acidic, cysteine-rich (osteonectin) |
|
decreases expression |
ISO |
10 |
40,809,730 |
40,831,481 |
RGD:6480464 |
CTD |
| G |
Spata7 |
spermatogenesis associated 7 |
|
increases expression |
ISO |
6 |
122,786,739 |
122,832,181 |
RGD:6480464 |
CTD |
| G |
Spin4 |
spindlin family, member 4 |
|
decreases expression |
ISO |
X |
82,564,580 |
82,565,329 |
RGD:6480464 |
CTD |
| G |
Spink1 |
serine peptidase inhibitor, Kazal type 1 |
|
increases expression |
ISO |
18 |
37,090,934 |
37,099,835 |
RGD:6480464 |
CTD |
| G |
Spon1 |
spondin 1, extracellular matrix protein |
|
decreases expression |
ISO |
1 |
171,700,495 |
172,020,808 |
RGD:6480464 |
CTD |
| G |
Sptlc3 |
serine palmitoyltransferase, long chain base subunit 3 |
|
decreases expression |
ISO |
3 |
127,691,668 |
127,825,206 |
RGD:6480464 |
CTD |
| G |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
|
increases expression |
ISO |
4 |
148,562,981 |
148,798,613 |
RGD:6480464 |
CTD |
| G |
Srgn |
serglycin |
|
increases expression |
ISO |
20 |
29,746,729 |
29,761,072 |
RGD:6480464 |
CTD |
| G |
Srxn1 |
sulfiredoxin 1 |
|
increases expression |
ISO |
3 |
142,457,352 |
142,462,725 |
RGD:6480464 |
CTD |
| G |
Ssuh2 |
ssu-2 homolog |
|
increases expression |
ISO |
4 |
148,211,602 |
148,229,983 |
RGD:6480464 |
CTD |
| G |
St18 |
suppression of tumorigenicity 18 |
|
increases expression |
ISO |
5 |
12,667,083 |
12,794,377 |
RGD:6480464 |
CTD |
| G |
St3gal1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
|
decreases expression |
ISO |
7 |
104,467,678 |
104,474,345 |
RGD:6480464 |
CTD |
| G |
St3gal6 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 6 |
|
decreases expression |
ISO |
11 |
42,893,712 |
42,937,792 |
RGD:6480464 |
CTD |
| G |
St6galnac3 |
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 |
|
decreases expression |
ISO |
2 |
251,284,792 |
251,701,550 |
RGD:6480464 |
CTD |
| G |
Stmn4 |
stathmin-like 4 |
|
increases response to substance |
ISO |
15 |
45,779,352 |
45,797,949 |
RGD:6480464 |
CTD |
| G |
Stom |
stomatin |
|
decreases expression |
ISO |
3 |
14,392,978 |
14,415,288 |
RGD:6480464 |
CTD |
| G |
Ston1 |
stonin 1 |
|
decreases expression |
ISO |
6 |
12,473,166 |
12,490,453 |
RGD:6480464 |
CTD |
| G |
Surf4 |
surfeit 4 |
|
decreases expression |
ISO |
3 |
5,817,200 |
5,830,060 |
RGD:6480464 |
CTD |
| G |
Svep1 |
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 |
|
decreases expression |
ISO |
5 |
76,025,177 |
76,203,391 |
RGD:6480464 |
CTD |
| G |
Sytl2 |
synaptotagmin-like 2 |
|
increases expression |
ISO |
1 |
146,977,959 |
147,084,664 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
increases expression |
ISO |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tac3 |
tachykinin 3 |
|
decreases expression |
ISO |
7 |
67,717,068 |
67,723,674 |
RGD:6480464 |
CTD |
| G |
Tagln |
transgelin |
|
increases expression |
ISO |
8 |
48,902,208 |
48,907,682 |
RGD:6480464 |
CTD |
| G |
Tceal7 |
transcription elongation factor A (SII)-like 7 |
|
increases expression |
ISO |
X |
123,537,652 |
123,539,744 |
RGD:6480464 |
CTD |
| G |
Tcf12 |
transcription factor 12 |
|
increases expression |
ISO |
8 |
76,311,327 |
76,498,091 |
RGD:6480464 |
CTD |
| G |
Tcf21 |
transcription factor 21 |
|
decreases expression |
ISO |
1 |
23,211,054 |
23,213,913 |
RGD:6480464 |
CTD |
| G |
Tcf25 |
transcription factor 25 (basic helix-loop-helix) |
|
decreases expression |
ISO |
19 |
53,700,698 |
53,732,930 |
RGD:6480464 |
CTD |
| G |
Tek |
TEK tyrosine kinase, endothelial |
|
decreases expression |
ISO |
5 |
115,047,195 |
115,196,172 |
RGD:6480464 |
CTD |
| G |
Tfe3 |
transcription factor binding to IGHM enhancer 3 |
|
increases expression |
ISO |
X |
26,768,875 |
26,781,006 |
RGD:6480464 |
CTD |
| G |
Tff3 |
trefoil factor 3, intestinal |
|
increases expression |
ISO |
20 |
9,469,888 |
9,474,604 |
RGD:6480464 |
CTD |
| G |
Tfpi |
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
|
decreases expression |
ISO |
3 |
67,654,389 |
67,697,178 |
RGD:6480464 |
CTD |
| G |
Tgfbr3 |
transforming growth factor, beta receptor III |
|
decreases expression |
ISO |
14 |
3,051,039 |
3,240,286 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Thbs1 |
thrombospondin 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Thy1 |
Thy-1 cell surface antigen |
|
decreases expression |
ISO |
8 |
47,027,721 |
47,031,857 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
decreases expression |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
affects response to substance |
ISO |
7 |
19,677,144 |
19,727,072 |
RGD:6480464 |
CTD |
| G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
decreases response to substance |
ISO |
7 |
19,677,144 |
19,727,072 |
RGD:6480464 |
CTD |
| G |
Tk1 |
thymidine kinase 1, soluble |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tk1 |
thymidine kinase 1, soluble |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tk2 |
thymidine kinase 2, mitochondrial |
|
decreases expression |
ISO |
19 |
667,538 |
689,556 |
RGD:6480464 |
CTD |
| G |
Tk2 |
thymidine kinase 2, mitochondrial |
|
decreases activity |
ISO |
19 |
667,538 |
689,556 |
RGD:6480464 |
CTD |
| G |
Tln2 |
talin 2 |
|
decreases expression |
ISO |
8 |
71,532,270 |
71,964,142 |
RGD:6480464 |
CTD |
| G |
Tmed1 |
transmembrane emp24 protein transport domain containing 1 |
|
decreases expression |
ISO |
8 |
20,611,139 |
20,613,714 |
RGD:6480464 |
CTD |
| G |
Tmed9 |
transmembrane emp24 protein transport domain containing 9 |
|
decreases expression |
ISO |
17 |
15,070,667 |
15,075,182 |
RGD:6480464 |
CTD |
| G |
Tmem200a |
transmembrane protein 200A |
|
decreases expression |
ISO |
1 |
19,783,813 |
19,869,008 |
RGD:6480464 |
CTD |
| G |
Tmem45a |
transmembrane protein 45A |
|
decreases expression |
ISO |
11 |
44,654,812 |
44,740,644 |
RGD:6480464 |
CTD |
| G |
Tmem62 |
transmembrane protein 62 |
|
increases expression |
ISO |
3 |
107,752,430 |
107,786,727 |
RGD:6480464 |
CTD |
| G |
Tmem66 |
transmembrane protein 66 |
|
decreases expression |
ISO |
16 |
61,744,563 |
61,762,812 |
RGD:6480464 |
CTD |
| G |
Tmem88 |
transmembrane protein 88 |
|
decreases expression |
ISO |
10 |
56,191,035 |
56,192,730 |
RGD:6480464 |
CTD |
| G |
Tmem98 |
transmembrane protein 98 |
|
decreases expression |
ISO |
10 |
69,028,338 |
69,039,247 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
multiple interactions |
ISO |
15 |
50,138,439 |
50,163,254 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
increases expression |
ISO |
15 |
50,138,439 |
50,163,254 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
increases expression |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnnt2 |
troponin T type 2 (cardiac) |
|
decreases expression |
ISO |
13 |
48,872,972 |
48,885,815 |
RGD:6480464 |
CTD |
| G |
Tnrc6a |
trinucleotide repeat containing 6a |
|
increases expression |
ISO |
1 |
181,982,994 |
182,053,510 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases phosphorylation |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases phosphorylation |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases phosphorylation |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases phosphorylation |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases phosphorylation |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53i11 |
tumor protein p53 inducible protein 11 |
|
increases response to substance |
ISO |
3 |
77,587,546 |
77,602,708 |
RGD:6480464 |
CTD |
| G |
Tpk1 |
thiamin pyrophosphokinase 1 |
|
decreases expression |
ISO |
4 |
71,113,965 |
71,521,331 |
RGD:6480464 |
CTD |
| G |
Tpst1 |
tyrosylprotein sulfotransferase 1 |
|
decreases expression |
ISO |
12 |
27,585,380 |
27,648,581 |
RGD:6480464 |
CTD |
| G |
Trim5 |
tripartite motif-containing 5 |
|
decreases expression |
ISO |
1 |
162,096,439 |
162,113,409 |
RGD:6480464 |
CTD |
| G |
Trim6 |
tripartite motif containing 6 |
|
decreases expression |
ISO |
1 |
162,059,220 |
162,094,672 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
affects localization |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv2 |
transient receptor potential cation channel, subfamily V, member 2 |
|
decreases expression |
ISO |
10 |
48,764,894 |
48,786,150 |
RGD:6480464 |
CTD |
| G |
Tspan4 |
tetraspanin 4 |
|
decreases expression |
ISO |
1 |
201,661,391 |
201,681,042 |
RGD:6480464 |
CTD |
| G |
Tspo |
translocator protein |
|
decreases expression |
ISO |
7 |
121,597,084 |
121,599,342 |
RGD:6480464 |
CTD |
| G |
Tst |
thiosulfate sulfurtransferase |
|
decreases expression |
ISO |
7 |
116,349,579 |
116,355,921 |
RGD:6480464 |
CTD |
| G |
Ttyh1 |
tweety homolog 1 (Drosophila) |
|
increases expression |
ISO |
1 |
69,465,633 |
69,483,549 |
RGD:6480464 |
CTD |
| G |
Tubb3 |
tubulin, beta 3 class III |
|
decreases expression |
ISO |
19 |
53,742,652 |
53,751,706 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
affects response to substance |
ISO |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
increases activity |
ISO |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Ube2c |
ubiquitin-conjugating enzyme E2C |
|
decreases expression |
ISO |
3 |
155,800,357 |
155,802,757 |
RGD:6480464 |
CTD |
| G |
Ubl3 |
ubiquitin-like 3 |
|
increases expression |
ISO |
12 |
7,019,485 |
7,063,818 |
RGD:6480464 |
CTD |
| G |
Usp7 |
ubiquitin specific peptidase 7 (herpes virus-associated) |
|
decreases expression |
ISO |
10 |
6,917,612 |
6,963,452 |
RGD:6480464 |
CTD |
| G |
Vasn |
vasorin |
|
decreases expression |
ISO |
10 |
11,047,084 |
11,057,591 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
increases expression |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
affects response to substance |
ISO |
7 |
136,567,614 |
136,617,280 |
RGD:6480464 |
CTD |
| G |
Vezf1 |
vascular endothelial zinc finger 1 |
|
increases expression |
ISO |
10 |
76,364,360 |
76,374,956 |
RGD:6480464 |
CTD |
| G |
Vgll4 |
vestigial like 4 (Drosophila) |
|
decreases expression |
ISO |
4 |
150,995,533 |
151,055,736 |
RGD:6480464 |
CTD |
| G |
Vrk2 |
vaccinia related kinase 2 |
|
decreases expression |
ISO |
14 |
107,287,844 |
107,450,960 |
RGD:6480464 |
CTD |
| G |
Wfdc3 |
WAP four-disulfide core domain 3 |
|
decreases expression |
ISO |
3 |
155,747,773 |
155,772,497 |
RGD:6480464 |
CTD |
| G |
Wipf1 |
WAS/WASL interacting protein family, member 1 |
|
decreases expression |
ISO |
3 |
55,944,490 |
56,003,310 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
increases response to substance |
ISO |
X |
3,011,520 |
3,047,798 |
RGD:6480464 |
CTD |
| G |
Xrcc1 |
X-ray repair complementing defective repair in Chinese hamster cells 1 |
|
increases expression |
ISO |
1 |
79,834,167 |
79,860,300 |
RGD:6480464 |
CTD |
| G |
Yif1a |
Yip1 interacting factor homolog A (S. cerevisiae) |
|
decreases expression |
ISO |
1 |
207,711,277 |
207,715,338 |
RGD:6480464 |
CTD |
| G |
Zc3hav1 |
zinc finger CCCH type, antiviral 1 |
|
decreases expression |
ISO |
4 |
65,854,471 |
65,894,691 |
RGD:6480464 |
CTD |
| G |
Zfhx4 |
zinc finger homeobox 4 |
|
increases expression |
ISO |
2 |
98,549,509 |
98,734,901 |
RGD:6480464 |
CTD |
| G |
Zfp423 |
zinc finger protein 423 |
|
increases expression |
ISO |
19 |
20,475,864 |
20,739,236 |
RGD:6480464 |
CTD |
| G |
Zfp467 |
zinc finger protein 467 |
|
decreases expression |
ISO |
4 |
76,522,000 |
76,528,470 |
RGD:6480464 |
CTD |
| G |
Zfpm2 |
zinc finger protein, multitype 2 |
|
decreases expression |
ISO |
7 |
76,210,472 |
76,654,443 |
RGD:6480464 |
CTD |
cytidine
|
| G |
Adora1 |
adenosine A1 receptor |
|
increases activity |
EXP |
13 |
47,160,292 |
47,192,804 |
RGD:6480464 |
CTD |
| G |
Adora2a |
adenosine A2a receptor |
|
increases activity |
EXP |
20 |
13,815,719 |
13,834,131 |
RGD:6480464 |
CTD |
| G |
Slc28a1 |
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
|
multiple interactions |
ISO |
1 |
137,323,995 |
137,365,983 |
RGD:6480464 |
CTD |
| G |
Slc28a1 |
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
|
increases transport |
ISO |
1 |
137,323,995 |
137,365,983 |
RGD:6480464 |
CTD |
| G |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
multiple interactions |
ISO |
9 |
11,000,054 |
11,014,914 |
RGD:6480464 |
CTD |
| G |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
multiple interactions |
EXP |
9 |
11,000,054 |
11,014,914 |
RGD:6480464 |
CTD |
| G |
Slc29a2 |
solute carrier family 29 (nucleoside transporters), member 2 |
|
multiple interactions |
ISO |
1 |
207,643,719 |
207,650,360 |
RGD:6480464 |
CTD |
| G |
Upp1 |
uridine phosphorylase 1 |
|
increases metabolic processing |
ISO |
14 |
89,651,264 |
89,669,630 |
RGD:6480464 |
CTD |
dihydroorotic acid
|
| G |
Dhodh |
dihydroorotate dehydrogenase (quinone) |
|
multiple interactions |
ISO |
19 |
39,463,111 |
39,477,184 |
RGD:6480464 |
CTD |
| G |
Dhodh |
dihydroorotate dehydrogenase (quinone) |
|
multiple interactions |
ISO |
19 |
39,463,111 |
39,477,184 |
RGD:6480464 |
CTD |
| G |
Dhodh |
dihydroorotate dehydrogenase (quinone) |
|
multiple interactions |
EXP |
19 |
39,463,111 |
39,477,184 |
RGD:6480464 |
CTD |
| G |
Dhodh |
dihydroorotate dehydrogenase (quinone) |
|
multiple interactions |
EXP |
19 |
39,463,111 |
39,477,184 |
RGD:6480464 |
CTD |
| G |
Dhodh |
dihydroorotate dehydrogenase (quinone) |
|
increases oxidation |
EXP |
19 |
39,463,111 |
39,477,184 |
RGD:6480464 |
CTD |
flucytosine
|
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases expression |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
hydramethylnon
|
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
affects binding |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
lamivudine
|
| G |
Acadsb |
acyl-CoA dehydrogenase, short/branched chain |
|
multiple interactions |
ISO |
1 |
190,987,657 |
191,026,275 |
RGD:6480464 |
CTD |
| G |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
|
multiple interactions |
ISO |
10 |
39,729,805 |
39,778,106 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Aebp1 |
AE binding protein 1 |
|
multiple interactions |
ISO |
14 |
86,525,748 |
86,535,664 |
RGD:6480464 |
CTD |
| G |
Afap1 |
actin filament associated protein 1 |
|
multiple interactions |
ISO |
14 |
80,355,358 |
80,448,224 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
affects binding |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
affects binding |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
|
multiple interactions |
ISO |
12 |
6,245,808 |
6,269,796 |
RGD:6480464 |
CTD |
| G |
Aqp9 |
aquaporin 9 |
|
multiple interactions |
ISO |
8 |
75,611,485 |
75,651,646 |
RGD:6480464 |
CTD |
| G |
Arpp21 |
cAMP-regulated phosphoprotein 21 |
|
multiple interactions |
ISO |
8 |
116,674,803 |
116,794,799 |
RGD:6480464 |
CTD |
| G |
Asic2 |
acid-sensing (proton-gated) ion channel 2 |
|
multiple interactions |
ISO |
10 |
69,103,244 |
70,190,305 |
RGD:6480464 |
CTD |
| G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
|
multiple interactions |
ISO |
4 |
32,758,866 |
32,776,220 |
RGD:6480464 |
CTD |
| G |
Ass1 |
argininosuccinate synthase 1 |
|
multiple interactions |
ISO |
3 |
10,578,717 |
10,622,332 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
multiple interactions |
ISO |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
multiple interactions |
ISO |
12 |
35,266,600 |
35,316,237 |
RGD:6480464 |
CTD |
| G |
Atp5c1 |
ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 |
|
multiple interactions |
ISO |
17 |
79,738,999 |
79,761,176 |
RGD:6480464 |
CTD |
| G |
Atp5g3 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9) |
|
multiple interactions |
ISO |
3 |
56,511,747 |
56,514,204 |
RGD:6480464 |
CTD |
| G |
Atp5h |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d |
|
multiple interactions |
ISO |
10 |
105,474,107 |
105,499,413 |
RGD:6480464 |
CTD |
| G |
Atp5j |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6 |
|
multiple interactions |
ISO |
11 |
24,316,748 |
24,323,800 |
RGD:6480464 |
CTD |
| G |
Atp5j2 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2 |
|
multiple interactions |
ISO |
12 |
9,735,171 |
9,741,496 |
RGD:6480464 |
CTD |
| G |
Atp5o |
ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit |
|
multiple interactions |
ISO |
11 |
31,914,320 |
31,920,632 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
C1r |
complement component 1, r subcomponent |
|
multiple interactions |
ISO |
4 |
160,712,582 |
160,729,362 |
RGD:6480464 |
CTD |
| G |
C3ar1 |
complement component 3a receptor 1 |
|
multiple interactions |
ISO |
4 |
159,326,402 |
159,333,433 |
RGD:6480464 |
CTD |
| G |
Cars |
cysteinyl-tRNA synthetase |
|
multiple interactions |
ISO |
1 |
203,934,812 |
203,977,042 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
multiple interactions |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
decreases expression |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccnc |
cyclin C |
|
multiple interactions |
ISO |
5 |
36,465,490 |
36,483,538 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
decreases expression |
ISO |
4 |
163,523,817 |
163,546,501 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
multiple interactions |
ISO |
4 |
163,523,817 |
163,546,501 |
RGD:6480464 |
CTD |
| G |
Ccne2 |
cyclin E2 |
|
multiple interactions |
ISO |
5 |
25,032,748 |
25,044,509 |
RGD:6480464 |
CTD |
| G |
Ccne2 |
cyclin E2 |
|
decreases expression |
ISO |
5 |
25,032,748 |
25,044,509 |
RGD:6480464 |
CTD |
| G |
Ccrn4l |
CCR4 carbon catabolite repression 4-like (S. cerevisiae) |
|
multiple interactions |
ISO |
2 |
140,120,310 |
140,140,518 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
multiple interactions |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
multiple interactions |
ISO |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cd83 |
CD83 molecule |
|
multiple interactions |
ISO |
17 |
26,705,646 |
26,725,470 |
RGD:6480464 |
CTD |
| G |
Cdk7 |
cyclin-dependent kinase 7 |
|
multiple interactions |
ISO |
2 |
31,500,629 |
31,525,590 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
multiple interactions |
ISO |
1 |
203,835,215 |
203,837,844 |
RGD:6480464 |
CTD |
| G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
|
multiple interactions |
ISO |
5 |
131,012,524 |
131,017,679 |
RGD:6480464 |
CTD |
| G |
Cfd |
complement factor D (adipsin) |
|
multiple interactions |
ISO |
7 |
11,325,538 |
11,327,261 |
RGD:6480464 |
CTD |
| G |
Cidec |
cell death-inducing DFFA-like effector c |
|
multiple interactions |
ISO |
4 |
149,307,986 |
149,321,303 |
RGD:6480464 |
CTD |
| G |
Clcn3 |
chloride channel, voltage-sensitive 3 |
|
multiple interactions |
ISO |
16 |
32,447,259 |
32,518,533 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
multiple interactions |
ISO |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Cox5a |
cytochrome c oxidase, subunit Va |
|
multiple interactions |
ISO |
8 |
61,264,971 |
61,276,380 |
RGD:6480464 |
CTD |
| G |
Cox5b |
cytochrome c oxidase subunit Vb |
|
multiple interactions |
ISO |
9 |
35,625,478 |
35,627,304 |
RGD:6480464 |
CTD |
| G |
Cox6a1 |
cytochrome c oxidase, subunit VIa, polypeptide 1 |
|
multiple interactions |
ISO |
12 |
42,530,091 |
42,533,144 |
RGD:6480464 |
CTD |
| G |
Cox6c |
cytochrome c oxidase, subunit VIc |
|
multiple interactions |
ISO |
7 |
71,465,790 |
71,478,524 |
RGD:6480464 |
CTD |
| G |
Cox7c |
cytochrome c oxidase, subunit VIIc |
|
multiple interactions |
ISO |
2 |
15,254,040 |
15,256,065 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
multiple interactions |
ISO |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Crat |
carnitine O-acetyltransferase |
|
multiple interactions |
ISO |
3 |
9,447,585 |
9,461,180 |
RGD:6480464 |
CTD |
| G |
Cul7 |
cullin 7 |
|
multiple interactions |
ISO |
9 |
10,020,543 |
10,034,167 |
RGD:6480464 |
CTD |
| G |
Cyb5a |
cytochrome b5 type A (microsomal) |
|
multiple interactions |
ISO |
18 |
81,415,972 |
81,452,606 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Dck |
deoxycytidine kinase |
|
multiple interactions |
ISO |
14 |
20,886,700 |
20,904,305 |
RGD:6480464 |
CTD |
| G |
Dcn |
decorin |
|
multiple interactions |
ISO |
7 |
35,004,234 |
35,045,191 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
multiple interactions |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Dhfr |
dihydrofolate reductase |
|
multiple interactions |
ISO |
2 |
22,607,093 |
22,828,487 |
RGD:6480464 |
CTD |
| G |
Diablo |
diablo, IAP-binding mitochondrial protein |
|
multiple interactions |
ISO |
12 |
34,196,347 |
34,209,633 |
RGD:6480464 |
CTD |
| G |
Diablo |
diablo, IAP-binding mitochondrial protein |
|
multiple interactions |
ISO |
12 |
34,196,347 |
34,209,633 |
RGD:6480464 |
CTD |
| G |
Dlst |
dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) |
|
multiple interactions |
ISO |
6 |
109,156,751 |
109,180,537 |
RGD:6480464 |
CTD |
| G |
Dnaja3 |
DnaJ (Hsp40) homolog, subfamily A, member 3 |
|
multiple interactions |
ISO |
10 |
10,984,721 |
11,009,374 |
RGD:6480464 |
CTD |
| G |
Dusp3 |
dual specificity phosphatase 3 |
|
multiple interactions |
ISO |
10 |
91,031,206 |
91,044,858 |
RGD:6480464 |
CTD |
| G |
Echs1 |
enoyl CoA hydratase, short chain, 1, mitochondrial |
|
multiple interactions |
ISO |
1 |
199,901,585 |
199,910,412 |
RGD:6480464 |
CTD |
| G |
Eci1 |
enoyl-CoA delta isomerase 1 |
|
multiple interactions |
ISO |
10 |
13,683,000 |
13,697,179 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
multiple interactions |
ISO |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Elovl3 |
ELOVL fatty acid elongase 3 |
|
multiple interactions |
ISO |
1 |
251,351,908 |
251,355,736 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Etv6 |
ets variant 6 |
|
multiple interactions |
ISO |
4 |
170,909,412 |
171,150,381 |
RGD:6480464 |
CTD |
| G |
Fads2 |
fatty acid desaturase 2 |
|
multiple interactions |
ISO |
1 |
212,512,691 |
212,542,622 |
RGD:6480464 |
CTD |
| G |
Faim |
Fas apoptotic inhibitory molecule |
|
multiple interactions |
ISO |
8 |
9,522,803 |
9,539,269 |
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fdxr |
ferredoxin reductase |
|
multiple interactions |
ISO |
10 |
105,342,684 |
105,351,374 |
RGD:6480464 |
CTD |
| G |
Fh |
fumarate hydratase |
|
multiple interactions |
ISO |
13 |
91,329,837 |
91,355,722 |
RGD:6480464 |
CTD |
| G |
G0s2 |
G0/G1switch 2 |
|
multiple interactions |
ISO |
13 |
109,121,297 |
109,122,209 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
multiple interactions |
ISO |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
Ganc |
glucosidase, alpha; neutral C |
|
multiple interactions |
ISO |
3 |
106,892,422 |
106,944,283 |
RGD:6480464 |
CTD |
| G |
Gars |
glycyl-tRNA synthetase |
|
multiple interactions |
ISO |
4 |
83,718,584 |
83,759,591 |
RGD:6480464 |
CTD |
| G |
Grhl2 |
grainyhead-like 2 (Drosophila) |
|
multiple interactions |
ISO |
7 |
72,742,859 |
72,872,351 |
RGD:6480464 |
CTD |
| G |
Gucy1b3 |
guanylate cyclase 1, soluble, beta 3 |
|
multiple interactions |
ISO |
2 |
173,683,153 |
173,735,298 |
RGD:6480464 |
CTD |
| G |
Hadh |
hydroxyacyl-CoA dehydrogenase |
|
multiple interactions |
ISO |
2 |
228,698,545 |
228,751,691 |
RGD:6480464 |
CTD |
| G |
Hadha |
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit |
|
multiple interactions |
ISO |
6 |
26,173,798 |
26,191,433 |
RGD:6480464 |
CTD |
| G |
Hax1 |
HCLS1 associated protein X-1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hcn1 |
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1 |
|
multiple interactions |
ISO |
2 |
49,525,949 |
49,939,066 |
RGD:6480464 |
CTD |
| G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
|
multiple interactions |
ISO |
2 |
193,128,736 |
193,143,106 |
RGD:6480464 |
CTD |
| G |
Hrk |
harakiri, BCL2 interacting protein (contains only BH3 domain) |
|
multiple interactions |
ISO |
12 |
39,520,265 |
39,543,901 |
RGD:6480464 |
CTD |
| G |
Hsd3b2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
|
multiple interactions |
ISO |
2 |
193,500,916 |
193,507,633 |
RGD:6480464 |
CTD |
| G |
Idh2 |
isocitrate dehydrogenase 2 (NADP+), mitochondrial |
|
multiple interactions |
ISO |
1 |
135,876,052 |
135,895,373 |
RGD:6480464 |
CTD |
| G |
Idh3a |
isocitrate dehydrogenase 3 (NAD+) alpha |
|
multiple interactions |
ISO |
8 |
58,135,412 |
58,156,019 |
RGD:6480464 |
CTD |
| G |
Idh3g |
isocitrate dehydrogenase 3 (NAD), gamma |
|
multiple interactions |
ISO |
X |
159,701,345 |
159,710,254 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
increases expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ikzf4 |
IKAROS family zinc finger 4 |
|
multiple interactions |
ISO |
7 |
1,928,510 |
1,948,712 |
RGD:6480464 |
CTD |
| G |
Il27ra |
interleukin 27 receptor, alpha |
|
multiple interactions |
ISO |
19 |
25,795,355 |
25,807,317 |
RGD:6480464 |
CTD |
| G |
Inpp5e |
inositol polyphosphate-5-phosphatase E |
|
multiple interactions |
ISO |
3 |
4,568,909 |
4,582,653 |
RGD:6480464 |
CTD |
| G |
Kcng1 |
potassium voltage-gated channel, subfamily G, member 1 |
|
multiple interactions |
ISO |
3 |
159,427,774 |
159,447,234 |
RGD:6480464 |
CTD |
| G |
Kifc2 |
kinesin family member C2 |
|
multiple interactions |
ISO |
7 |
114,710,367 |
114,717,778 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
multiple interactions |
ISO |
5 |
73,446,928 |
73,451,286 |
RGD:6480464 |
CTD |
| G |
Klhl28 |
kelch-like family member 28 |
|
multiple interactions |
ISO |
6 |
86,281,944 |
86,314,935 |
RGD:6480464 |
CTD |
| G |
Krt7 |
keratin 7 |
|
multiple interactions |
ISO |
7 |
140,160,829 |
140,226,474 |
RGD:6480464 |
CTD |
| G |
Kynu |
kynureninase |
|
multiple interactions |
ISO |
3 |
24,046,242 |
24,195,898 |
RGD:6480464 |
CTD |
| G |
Lamb3 |
laminin, beta 3 |
|
multiple interactions |
ISO |
13 |
109,148,815 |
109,190,322 |
RGD:6480464 |
CTD |
| G |
Lamc2 |
laminin, gamma 2 |
|
multiple interactions |
ISO |
13 |
68,151,074 |
68,211,117 |
RGD:6480464 |
CTD |
| G |
Lef1 |
lymphoid enhancer binding factor 1 |
|
multiple interactions |
ISO |
2 |
228,550,263 |
228,673,131 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
LOC100360940 |
diablo-like |
|
multiple interactions |
ISO |
5 |
148,562,065 |
148,563,619 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
decreases expression |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Ly6i |
lymphocyte antigen 6 complex, locus I |
|
multiple interactions |
ISO |
7 |
113,306,011 |
113,310,996 |
RGD:6480464 |
CTD |
| G |
Mars |
methionyl-tRNA synthetase |
|
multiple interactions |
ISO |
7 |
67,252,510 |
67,269,807 |
RGD:6480464 |
CTD |
| G |
Me1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
|
multiple interactions |
ISO |
8 |
91,839,845 |
91,955,917 |
RGD:6480464 |
CTD |
| G |
Me1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
|
increases expression |
ISO |
8 |
91,839,845 |
91,955,917 |
RGD:6480464 |
CTD |
| G |
Mfn1 |
mitofusin 1 |
|
multiple interactions |
ISO |
2 |
118,739,155 |
118,783,037 |
RGD:6480464 |
CTD |
| G |
Mfn2 |
mitofusin 2 |
|
multiple interactions |
ISO |
5 |
164,951,252 |
164,980,763 |
RGD:6480464 |
CTD |
| G |
Mgat4c |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) |
|
multiple interactions |
ISO |
7 |
40,171,454 |
40,383,441 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
increases expression |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mrap |
melanocortin 2 receptor accessory protein |
|
multiple interactions |
ISO |
11 |
30,720,783 |
30,731,275 |
RGD:6480464 |
CTD |
| G |
Mt-co1 |
mitochondrially encoded cytochrome c oxidase I |
|
multiple interactions |
ISO |
MT |
5,323 |
6,867 |
RGD:6480464 |
CTD |
| G |
Mt-co1 |
mitochondrially encoded cytochrome c oxidase I |
|
multiple interactions |
ISO |
MT |
5,323 |
6,867 |
RGD:6480464 |
CTD |
| G |
Mt-co2 |
mitochondrially encoded cytochrome c oxidase II |
|
multiple interactions |
ISO |
MT |
7,006 |
7,689 |
RGD:6480464 |
CTD |
| G |
Mt-co3 |
mitochondrially encoded cytochrome c oxidase III |
|
multiple interactions |
ISO |
MT |
8,599 |
9,382 |
RGD:6480464 |
CTD |
| G |
Mt-co3 |
mitochondrially encoded cytochrome c oxidase III |
|
multiple interactions |
ISO |
MT |
8,599 |
9,382 |
RGD:6480464 |
CTD |
| G |
Mt-nd2 |
mitochondrially encoded NADH dehydrogenase 2 |
|
multiple interactions |
ISO |
MT |
3,904 |
4,942 |
RGD:6480464 |
CTD |
| G |
Mt-nd5 |
mitochondrially encoded NADH dehydrogenase 5 |
|
multiple interactions |
ISO |
MT |
11,736 |
13,565 |
RGD:6480464 |
CTD |
| G |
Mt-nd5 |
mitochondrially encoded NADH dehydrogenase 5 |
|
multiple interactions |
ISO |
MT |
11,736 |
13,565 |
RGD:6480464 |
CTD |
| G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
|
multiple interactions |
ISO |
4 |
117,517,611 |
117,529,128 |
RGD:6480464 |
CTD |
| G |
Myod1 |
myogenic differentiation 1 |
|
multiple interactions |
ISO |
1 |
96,910,190 |
96,912,900 |
RGD:6480464 |
CTD |
| G |
Nap1l5 |
nucleosome assembly protein 1-like 5 |
|
multiple interactions |
ISO |
4 |
87,796,429 |
87,798,296 |
RGD:6480464 |
CTD |
| G |
Ndufa4 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4 |
|
multiple interactions |
ISO |
4 |
37,125,782 |
37,133,055 |
RGD:6480464 |
CTD |
| G |
Ndufab1 |
NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1 |
|
multiple interactions |
ISO |
1 |
180,908,331 |
180,921,734 |
RGD:6480464 |
CTD |
| G |
Ndufaf1 |
NADH dehydrogenase (ubiquinone) complex I, assembly factor 1 |
|
multiple interactions |
ISO |
3 |
106,171,381 |
106,181,742 |
RGD:6480464 |
CTD |
| G |
Ndufb3 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 3 |
|
multiple interactions |
ISO |
9 |
57,252,769 |
57,262,981 |
RGD:6480464 |
CTD |
| G |
Ndufb3 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 3 |
|
multiple interactions |
ISO |
9 |
57,252,769 |
57,262,981 |
RGD:6480464 |
CTD |
| G |
Ndufb3l |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 3-like |
|
multiple interactions |
ISO |
4 |
99,049,726 |
99,050,028 |
RGD:6480464 |
CTD |
| G |
Ndufb5 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5 |
|
multiple interactions |
ISO |
2 |
118,946,438 |
118,963,186 |
RGD:6480464 |
CTD |
| G |
Ndufb9 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9 |
|
multiple interactions |
ISO |
7 |
95,949,322 |
95,955,668 |
RGD:6480464 |
CTD |
| G |
Ndufc1 |
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1 |
|
multiple interactions |
ISO |
2 |
140,298,031 |
140,301,809 |
RGD:6480464 |
CTD |
| G |
Ndufs1 |
NADH dehydrogenase (ubiquinone) Fe-S protein 1 |
|
multiple interactions |
ISO |
9 |
61,798,141 |
61,831,964 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
multiple interactions |
ISO |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nup210 |
nucleoporin 210 |
|
multiple interactions |
ISO |
4 |
125,189,612 |
125,285,493 |
RGD:6480464 |
CTD |
| G |
Nxnl2 |
nucleoredoxin-like 2 |
|
multiple interactions |
ISO |
17 |
19,922,403 |
19,927,149 |
RGD:6480464 |
CTD |
| G |
Oaz3 |
ornithine decarboxylase antizyme 3 |
|
multiple interactions |
ISO |
2 |
189,408,566 |
189,411,500 |
RGD:6480464 |
CTD |
| G |
Ogt |
O-linked N-acetylglucosamine (GlcNAc) transferase |
|
multiple interactions |
ISO |
X |
89,721,369 |
89,766,218 |
RGD:6480464 |
CTD |
| G |
Opa1 |
optic atrophy 1 |
|
multiple interactions |
ISO |
11 |
73,005,470 |
73,058,136 |
RGD:6480464 |
CTD |
| G |
Oprl1 |
opiate receptor-like 1 |
|
multiple interactions |
ISO |
3 |
170,869,862 |
170,873,417 |
RGD:6480464 |
CTD |
| G |
Pck2 |
phosphoenolpyruvate carboxykinase 2 (mitochondrial) |
|
multiple interactions |
ISO |
15 |
33,671,834 |
33,680,613 |
RGD:6480464 |
CTD |
| G |
Peo1 |
progressive external ophthalmoplegia 1 |
|
multiple interactions |
ISO |
1 |
250,073,350 |
250,079,743 |
RGD:6480464 |
CTD |
| G |
Pfkfb3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
|
multiple interactions |
ISO |
17 |
78,241,182 |
78,268,272 |
RGD:6480464 |
CTD |
| G |
Phf6 |
PHD finger protein 6 |
|
multiple interactions |
ISO |
X |
139,850,136 |
139,890,670 |
RGD:6480464 |
CTD |
| G |
Pidd |
p53-induced death domain protein |
|
multiple interactions |
ISO |
1 |
201,626,042 |
201,631,182 |
RGD:6480464 |
CTD |
| G |
Piwil2 |
piwi-like RNA-mediated gene silencing 2 |
|
multiple interactions |
ISO |
15 |
50,757,820 |
50,823,943 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
decreases expression |
ISO |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Pou5f1 |
POU class 5 homeobox 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Prdm1 |
PR domain containing 1, with ZNF domain |
|
multiple interactions |
ISO |
20 |
48,438,224 |
48,459,848 |
RGD:6480464 |
CTD |
| G |
Prl2c1 |
Prolactin family 2, subfamily c, member 1 |
|
multiple interactions |
ISO |
17 |
43,420,887 |
43,429,208 |
RGD:6480464 |
CTD |
| G |
Psat1 |
phosphoserine aminotransferase 1 |
|
multiple interactions |
ISO |
1 |
219,268,419 |
219,290,273 |
RGD:6480464 |
CTD |
| G |
Rabepk |
Rab9 effector protein with kelch motifs |
|
multiple interactions |
ISO |
3 |
13,790,808 |
13,811,327 |
RGD:6480464 |
CTD |
| G |
Rbl1 |
retinoblastoma-like 1 (p107) |
|
multiple interactions |
ISO |
3 |
147,734,622 |
147,796,630 |
RGD:6480464 |
CTD |
| G |
Rbl2 |
retinoblastoma-like 2 |
|
multiple interactions |
ISO |
19 |
17,045,131 |
17,092,597 |
RGD:6480464 |
CTD |
| G |
Reep6 |
receptor accessory protein 6 |
|
multiple interactions |
ISO |
7 |
10,885,266 |
10,891,936 |
RGD:6480464 |
CTD |
| G |
Ripk2 |
receptor-interacting serine-threonine kinase 2 |
|
multiple interactions |
ISO |
5 |
30,714,817 |
30,745,941 |
RGD:6480464 |
CTD |
| G |
Rnf151 |
ring finger protein 151 |
|
multiple interactions |
ISO |
10 |
13,970,717 |
13,973,034 |
RGD:6480464 |
CTD |
| G |
Rpain |
RPA interacting protein |
|
multiple interactions |
ISO |
10 |
57,874,557 |
57,881,526 |
RGD:6480464 |
CTD |
| G |
S100a8 |
S100 calcium binding protein A8 |
|
multiple interactions |
ISO |
2 |
182,961,994 |
182,962,513 |
RGD:6480464 |
CTD |
| G |
Sdhb |
succinate dehydrogenase complex, subunit B, iron sulfur (Ip) |
|
multiple interactions |
ISO |
5 |
159,818,669 |
159,839,772 |
RGD:6480464 |
CTD |
| G |
Serinc1 |
serine incorporator 1 |
|
multiple interactions |
ISO |
20 |
36,541,193 |
36,560,101 |
RGD:6480464 |
CTD |
| G |
Sfxn1 |
sideroflexin 1 |
|
multiple interactions |
ISO |
17 |
16,601,066 |
16,636,502 |
RGD:6480464 |
CTD |
| G |
Sfxn4 |
sideroflexin 4 |
|
multiple interactions |
ISO |
1 |
267,443,207 |
267,465,488 |
RGD:6480464 |
CTD |
| G |
Sgpp1 |
sphingosine-1-phosphate phosphatase 1 |
|
multiple interactions |
ISO |
6 |
98,306,168 |
98,327,175 |
RGD:6480464 |
CTD |
| G |
Slc1a4 |
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
|
multiple interactions |
ISO |
14 |
101,123,740 |
101,153,790 |
RGD:6480464 |
CTD |
| G |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
|
multiple interactions |
ISO |
1 |
77,111,082 |
77,125,166 |
RGD:6480464 |
CTD |
| G |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
|
increases uptake |
ISO |
1 |
42,351,239 |
42,378,295 |
RGD:6480464 |
CTD |
| G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
|
increases uptake |
ISO |
1 |
42,395,676 |
42,442,847 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
increases uptake |
ISO |
1 |
42,690,158 |
42,781,895 |
RGD:6480464 |
CTD |
| G |
Slc25a15 |
solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15 |
|
multiple interactions |
ISO |
16 |
74,280,827 |
74,301,105 |
RGD:6480464 |
CTD |
| G |
Slc25a19 |
solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19 |
|
multiple interactions |
ISO |
10 |
105,694,526 |
105,707,452 |
RGD:6480464 |
CTD |
| G |
Slc25a19 |
solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19 |
|
multiple interactions |
ISO |
10 |
105,694,526 |
105,707,452 |
RGD:6480464 |
CTD |
| G |
Slc25a2 |
solute carrier family 25 (mitochondrial carrier, ornithine transporter) member 2 |
|
multiple interactions |
ISO |
18 |
30,536,488 |
30,537,684 |
RGD:6480464 |
CTD |
| G |
Slc25a20 |
solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 |
|
multiple interactions |
ISO |
8 |
113,715,211 |
113,737,063 |
RGD:6480464 |
CTD |
| G |
Slc25a29 |
solute carrier family 25 (mitochondrial carnitine/acylcarnitine carrier), member 29 |
|
multiple interactions |
ISO |
6 |
133,166,812 |
133,177,600 |
RGD:6480464 |
CTD |
| G |
Slc25a3 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 3 |
|
multiple interactions |
ISO |
7 |
28,054,665 |
28,061,801 |
RGD:6480464 |
CTD |
| G |
Slc25a4 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
|
multiple interactions |
ISO |
16 |
49,353,476 |
49,357,271 |
RGD:6480464 |
CTD |
| G |
Slc28a1 |
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
|
multiple interactions |
ISO |
1 |
137,323,995 |
137,365,983 |
RGD:6480464 |
CTD |
| G |
Slc31a1 |
solute carrier family 31 (copper transporters), member 1 |
|
multiple interactions |
ISO |
5 |
79,359,420 |
79,385,988 |
RGD:6480464 |
CTD |
| G |
Slc3a2 |
solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 |
|
multiple interactions |
ISO |
1 |
211,375,889 |
211,390,313 |
RGD:6480464 |
CTD |
| G |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
|
multiple interactions |
ISO |
9 |
44,977,430 |
44,995,358 |
RGD:6480464 |
CTD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
multiple interactions |
ISO |
10 |
67,134,790 |
67,155,891 |
RGD:6480464 |
CTD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
increases expression |
ISO |
10 |
67,134,790 |
67,155,891 |
RGD:6480464 |
CTD |
| G |
Spink5 |
serine peptidase inhibitor, Kazal type 5 |
|
multiple interactions |
ISO |
18 |
37,563,911 |
37,631,579 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
multiple interactions |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Stc2 |
stanniocalcin 2 |
|
multiple interactions |
ISO |
10 |
16,514,603 |
16,524,369 |
RGD:6480464 |
CTD |
| G |
Sub1 |
SUB1 homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
2 |
61,418,076 |
61,430,139 |
RGD:6480464 |
CTD |
| G |
Sval2 |
seminal vesicle antigen-like 2 |
|
multiple interactions |
ISO |
4 |
69,666,108 |
69,670,072 |
RGD:6480464 |
CTD |
| G |
Tcea1 |
transcription elongation factor A (SII) 1 |
|
multiple interactions |
ISO |
5 |
14,834,045 |
14,871,291 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
decreases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Timm17b |
translocase of inner mitochondrial membrane 17 homolog B (yeast) |
|
multiple interactions |
ISO |
X |
26,630,879 |
26,637,962 |
RGD:6480464 |
CTD |
| G |
Timm23 |
translocase of inner mitochondrial membrane 23 homolog (yeast) |
|
multiple interactions |
ISO |
16 |
7,663,204 |
7,689,233 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
decreases expression |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
multiple interactions |
ISO |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Tk2 |
thymidine kinase 2, mitochondrial |
|
multiple interactions |
ISO |
19 |
667,538 |
689,556 |
RGD:6480464 |
CTD |
| G |
Tmem8a |
transmembrane protein 8A |
|
multiple interactions |
ISO |
10 |
15,384,648 |
15,394,120 |
RGD:6480464 |
CTD |
| G |
Trib3 |
tribbles homolog 3 (Drosophila) |
|
multiple interactions |
ISO |
3 |
142,664,641 |
142,670,135 |
RGD:6480464 |
CTD |
| G |
Trim42 |
tripartite motif-containing 42 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
multiple interactions |
ISO |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Tyrp1 |
tyrosinase-related protein 1 |
|
multiple interactions |
ISO |
5 |
99,518,306 |
99,537,289 |
RGD:6480464 |
CTD |
| G |
Uqcrb |
ubiquinol-cytochrome c reductase binding protein |
|
multiple interactions |
ISO |
7 |
67,958,363 |
67,963,730 |
RGD:6480464 |
CTD |
| G |
Uqcrb-ps1 |
ubiquinol-cytochrome c reductase binding protein, pseudogene 1 |
|
multiple interactions |
ISO |
1 |
90,807,565 |
90,807,900 |
RGD:6480464 |
CTD |
| G |
Uqcrc1 |
ubiquinol-cytochrome c reductase core protein I |
|
multiple interactions |
ISO |
8 |
113,955,930 |
113,967,675 |
RGD:6480464 |
CTD |
| G |
Uqcrc1 |
ubiquinol-cytochrome c reductase core protein I |
|
multiple interactions |
ISO |
8 |
113,955,930 |
113,967,675 |
RGD:6480464 |
CTD |
| G |
Uqcrc2 |
ubiquinol cytochrome c reductase core protein 2 |
|
multiple interactions |
ISO |
1 |
179,459,817 |
179,490,381 |
RGD:6480464 |
CTD |
| G |
Vdac1 |
voltage-dependent anion channel 1 |
|
multiple interactions |
ISO |
10 |
37,795,721 |
37,823,253 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
multiple interactions |
ISO |
7 |
136,567,614 |
136,617,280 |
RGD:6480464 |
CTD |
| G |
Vps4b |
vacuolar protein sorting 4 homolog B (S. cerevisiae) |
|
multiple interactions |
ISO |
13 |
12,959,843 |
12,984,933 |
RGD:6480464 |
CTD |
| G |
Wars |
tryptophanyl-tRNA synthetase |
|
multiple interactions |
ISO |
6 |
133,200,866 |
133,232,048 |
RGD:6480464 |
CTD |
| G |
Wnt10a |
wingless-type MMTV integration site family, member 10A |
|
multiple interactions |
ISO |
9 |
74,124,403 |
74,137,508 |
RGD:6480464 |
CTD |
| G |
Yars |
tyrosyl-tRNA synthetase |
|
multiple interactions |
ISO |
5 |
148,350,363 |
148,378,989 |
RGD:6480464 |
CTD |
orotic acid
|
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4a2 |
cytochrome P450, family 4, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
5 |
135,765,673 |
135,773,006 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
affects abundance |
ISO |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
EXP |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
increases phosphorylation |
ISO |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
multiple interactions |
ISO |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
Rptor |
regulatory associated protein of MTOR, complex 1 |
|
decreases phosphorylation |
ISO |
10 |
109,000,666 |
109,302,700 |
RGD:6480464 |
CTD |
| G |
Rptor |
regulatory associated protein of MTOR, complex 1 |
|
multiple interactions |
ISO |
10 |
109,000,666 |
109,302,700 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
multiple interactions |
EXP |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
Stk11 |
serine/threonine kinase 11 |
|
multiple interactions |
ISO |
7 |
11,086,760 |
11,103,522 |
RGD:6480464 |
CTD |
pyrimidine
|
| G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
|
decreases activity |
ISO |
17 |
77,084,306 |
77,112,994 |
RGD:6480464 |
CTD |
| G |
Upp1 |
uridine phosphorylase 1 |
|
increases metabolic processing |
ISO |
14 |
89,651,264 |
89,669,630 |
RGD:6480464 |
CTD |
sulfamethazine
|
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases activity |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
increases acetylation |
ISO |
16 |
23,855,555 |
23,876,531 |
RGD:6480464 |
CTD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
increases acetylation |
ISO |
16 |
23,855,555 |
23,876,531 |
RGD:6480464 |
CTD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
increases acetylation |
ISO |
16 |
23,855,555 |
23,876,531 |
RGD:6480464 |
CTD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
increases acetylation |
ISO |
16 |
23,855,555 |
23,876,531 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
increases activity |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
UDP
|
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Gpr17 |
G protein-coupled receptor 17 |
|
multiple interactions |
ISO |
18 |
24,374,253 |
24,375,272 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
P2ry6 |
pyrimidinergic receptor P2Y, G-protein coupled, 6 |
|
multiple interactions |
ISO |
1 |
158,381,127 |
158,406,783 |
RGD:6480464 |
CTD |
| G |
P2ry6 |
pyrimidinergic receptor P2Y, G-protein coupled, 6 |
|
affects response to substance |
ISO |
1 |
158,381,127 |
158,406,783 |
RGD:6480464 |
CTD |
UDP-alpha-D-galactose
|
| G |
Gpr17 |
G protein-coupled receptor 17 |
|
increases activity |
ISO |
18 |
24,374,253 |
24,375,272 |
RGD:6480464 |
CTD |
UDP-alpha-D-glucuronic acid
|
| G |
B3gat3 |
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) |
|
affects binding |
ISO |
1 |
211,597,624 |
211,604,142 |
RGD:6480464 |
CTD |
| G |
B3gat3 |
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) |
|
multiple interactions |
ISO |
1 |
211,597,624 |
211,604,142 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
increases expression |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
multiple interactions |
ISO |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt2b7 |
UDP glucuronosyltransferase 2 family, polypeptide B7 |
|
multiple interactions |
ISO |
14 |
22,499,152 |
22,522,842 |
RGD:6480464 |
CTD |
UDP-D-galactose
|
| G |
Gpr17 |
G protein-coupled receptor 17 |
|
increases activity |
ISO |
18 |
24,374,253 |
24,375,272 |
RGD:6480464 |
CTD |
UDP-D-glucose
|
| G |
Gpr17 |
G protein-coupled receptor 17 |
|
increases activity |
ISO |
18 |
24,374,253 |
24,375,272 |
RGD:6480464 |
CTD |
uracil
|
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
uridine
|
| G |
Adora1 |
adenosine A1 receptor |
|
increases activity |
EXP |
13 |
47,160,292 |
47,192,804 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
increases expression |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Mt-co1 |
mitochondrially encoded cytochrome c oxidase I |
|
multiple interactions |
ISO |
MT |
5,323 |
6,867 |
RGD:6480464 |
CTD |
| G |
Mt-co1 |
mitochondrially encoded cytochrome c oxidase I |
|
multiple interactions |
ISO |
MT |
5,323 |
6,867 |
RGD:6480464 |
CTD |
| G |
Mt-co1 |
mitochondrially encoded cytochrome c oxidase I |
|
multiple interactions |
ISO |
MT |
5,323 |
6,867 |
RGD:6480464 |
CTD |
| G |
Mt-co1 |
mitochondrially encoded cytochrome c oxidase I |
|
multiple interactions |
ISO |
MT |
5,323 |
6,867 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
multiple interactions |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Slc28a1 |
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
|
multiple interactions |
ISO |
1 |
137,323,995 |
137,365,983 |
RGD:6480464 |
CTD |
| G |
Slc28a1 |
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
|
multiple interactions |
ISO |
1 |
137,323,995 |
137,365,983 |
RGD:6480464 |
CTD |
| G |
Slc28a1 |
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
|
increases uptake |
ISO |
1 |
137,323,995 |
137,365,983 |
RGD:6480464 |
CTD |
| G |
Slc28a1 |
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
|
increases transport |
ISO |
1 |
137,323,995 |
137,365,983 |
RGD:6480464 |
CTD |
| G |
Slc28a1 |
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
|
multiple interactions |
EXP |
1 |
137,323,995 |
137,365,983 |
RGD:6480464 |
CTD |
| G |
Slc28a1 |
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
|
increases export |
EXP |
1 |
137,323,995 |
137,365,983 |
RGD:6480464 |
CTD |
| G |
Slc28a1 |
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
|
increases uptake |
EXP |
1 |
137,323,995 |
137,365,983 |
RGD:6480464 |
CTD |
| G |
Slc28a1 |
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
|
multiple interactions |
EXP |
1 |
137,323,995 |
137,365,983 |
RGD:6480464 |
CTD |
| G |
Slc28a1 |
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
|
increases uptake |
EXP |
1 |
137,323,995 |
137,365,983 |
RGD:6480464 |
CTD |
| G |
Slc28a2 |
solute carrier family 28 (sodium-coupled nucleoside transporter), member 2 |
|
increases transport |
ISO |
3 |
109,350,531 |
109,372,027 |
RGD:6480464 |
CTD |
| G |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
increases uptake |
ISO |
9 |
11,000,054 |
11,014,914 |
RGD:6480464 |
CTD |
| G |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
multiple interactions |
ISO |
9 |
11,000,054 |
11,014,914 |
RGD:6480464 |
CTD |
| G |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
multiple interactions |
ISO |
9 |
11,000,054 |
11,014,914 |
RGD:6480464 |
CTD |
| G |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
multiple interactions |
ISO |
9 |
11,000,054 |
11,014,914 |
RGD:6480464 |
CTD |
| G |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
multiple interactions |
ISO |
9 |
11,000,054 |
11,014,914 |
RGD:6480464 |
CTD |
| G |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
increases uptake |
ISO |
9 |
11,000,054 |
11,014,914 |
RGD:6480464 |
CTD |
| G |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
multiple interactions |
ISO |
9 |
11,000,054 |
11,014,914 |
RGD:6480464 |
CTD |
| G |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
increases uptake |
ISO |
9 |
11,000,054 |
11,014,914 |
RGD:6480464 |
CTD |
| G |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
multiple interactions |
EXP |
9 |
11,000,054 |
11,014,914 |
RGD:6480464 |
CTD |
| G |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
increases uptake |
EXP |
9 |
11,000,054 |
11,014,914 |
RGD:6480464 |
CTD |
| G |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
increases uptake |
ISO |
9 |
11,000,054 |
11,014,914 |
RGD:6480464 |
CTD |
| G |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
increases uptake |
ISO |
9 |
11,000,054 |
11,014,914 |
RGD:6480464 |
CTD |
| G |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
increases uptake |
ISO |
9 |
11,000,054 |
11,014,914 |
RGD:6480464 |
CTD |
| G |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
increases uptake |
ISO |
9 |
11,000,054 |
11,014,914 |
RGD:6480464 |
CTD |
| G |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
increases uptake |
ISO |
9 |
11,000,054 |
11,014,914 |
RGD:6480464 |
CTD |
| G |
Slc29a2 |
solute carrier family 29 (nucleoside transporters), member 2 |
|
multiple interactions |
ISO |
1 |
207,643,719 |
207,650,360 |
RGD:6480464 |
CTD |
| G |
Slc29a2 |
solute carrier family 29 (nucleoside transporters), member 2 |
|
increases uptake |
ISO |
1 |
207,643,719 |
207,650,360 |
RGD:6480464 |
CTD |
| G |
Slc29a2 |
solute carrier family 29 (nucleoside transporters), member 2 |
|
multiple interactions |
ISO |
1 |
207,643,719 |
207,650,360 |
RGD:6480464 |
CTD |
| G |
Slc29a2 |
solute carrier family 29 (nucleoside transporters), member 2 |
|
increases uptake |
ISO |
1 |
207,643,719 |
207,650,360 |
RGD:6480464 |
CTD |
| G |
Slc29a2 |
solute carrier family 29 (nucleoside transporters), member 2 |
|
increases uptake |
EXP |
1 |
207,643,719 |
207,650,360 |
RGD:6480464 |
CTD |
| G |
Slc29a2 |
solute carrier family 29 (nucleoside transporters), member 2 |
|
increases uptake |
ISO |
1 |
207,643,719 |
207,650,360 |
RGD:6480464 |
CTD |
| G |
Upp1 |
uridine phosphorylase 1 |
|
affects abundance |
ISO |
14 |
89,651,264 |
89,669,630 |
RGD:6480464 |
CTD |
| G |
Upp1 |
uridine phosphorylase 1 |
|
increases metabolic processing |
ISO |
14 |
89,651,264 |
89,669,630 |
RGD:6480464 |
CTD |
| G |
Upp1 |
uridine phosphorylase 1 |
|
multiple interactions |
ISO |
14 |
89,651,264 |
89,669,630 |
RGD:6480464 |
CTD |
UTP
|
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
multiple interactions |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases phosphorylation |
EXP |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Gnaq |
guanine nucleotide binding protein (G protein), q polypeptide |
|
multiple interactions |
EXP |
1 |
219,520,998 |
219,764,401 |
RGD:6480464 |
CTD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
multiple interactions |
ISO |
12 |
33,863,876 |
33,864,958 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Myl2 |
myosin, light chain 2, regulatory, cardiac, slow |
|
multiple interactions |
EXP |
12 |
35,653,745 |
35,664,700 |
RGD:6480464 |
CTD |
| G |
Myocd |
myocardin |
|
multiple interactions |
EXP |
10 |
51,496,223 |
51,588,226 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
multiple interactions |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
increases expression |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
P2ry2 |
purinergic receptor P2Y, G-protein coupled, 2 |
|
multiple interactions |
EXP |
1 |
158,440,018 |
158,454,213 |
RGD:6480464 |
CTD |
| G |
P2ry4 |
pyrimidine | |